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1 Introduction 
1.1 Metabolic disorders of epidemic proportions in the 21st century 
1.1.1  Obesity 
Hardly any other epidemic in history has been as apparent as the current global rise in the 
prevalence of overweight and obesity (Figure 1.1). Over the last 30 years the worldwide 
incidences of obesity have nearly doubled to approximately 500 million obese and 1.4 
billion overweight people in 2008 (WHO, 2013c).  
 
 
Figure 1.1: Schematic illustration of the global obesity and diabetes epidemic  
Over the last decades, the prevalence of obesity has dramatically increased, affecting approximately 
20 % of the adult population in Central Europe and 30 % in the United States of America (USA). 
Similarly, Diabetes mellitus is diagnosed in approximately 5-7 % and 7-9 % in Central Europe and 
the USA, respectively. Illustrations were adapted from the World Health Organization and the 
International Diabetes Federation (WHO and IDF). 
 
 
Overweight and obesity are commonly assessed by the body mass index (BMI). The 
BMI is calculated by the body weight in kilogram divided by the square of the height in 
meter [kg/m2] of an individual (WHO, 2013c). Whereas a normal BMI ranges from 18.5 to 
24.9, a person with a BMI above or equal to 25 is considered overweight and even diagnosed 
with obesity, if the BMI is equal to, or exceeds the critical threshold of 30 (WHO, 2013c). 
However, the BMI as a measure of adiposity has been criticized as it neglects to distinguish 
between fat and lean mass, as well as between the distribution of body fat (Snijder et al., 
2006). Intra-abdominal or visceral fat is considered to confer greater risk to develop obesity-
associated diseases than subcutaneous fat (Bergman et al., 2006). Therefore, measures other 
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than the BMI, such as the waist-to-hip ratio, the waist circumference, or the body fat 
percentage have been applied to categorize an individual’s state of adiposity (Snijder et al., 
2006). Nevertheless, due to the inexpensive and simple measures needed to determine the 
BMI, as well as the large amount of epidemiological data available in the literature, the BMI 
is still the most commonly used measure to correlate an individual’s state of adiposity with 
the associated risks to develop certain co-morbidities.  
Generally, obesity develops when the overall caloric intake exceeds the calories 
expended. Such a chronic imbalance in energy homeostasis can have long-term 
consequences: Apart from psychological problems resulting e.g. from social exclusion and 
subsequent introversion, overweight and/or obesity can lead to the development of Type 2 
Diabetes mellitus (T2DM), cardiovascular diseases, stroke and certain forms of cancer (i.e. 
endometrial, colon and breast cancer), linking overweight and obesity to the deaths of 
approximately 2.8 million people per year (WHO, 2013c).  As a consequence, recent 
prognoses predict an overall decline in life expectancy for the first time in centuries 
(Olshansky et al., 2005).  
In light of these developments, efforts have been made to identify the underlying 
causes responsible for the obesity epidemic. Although rare monogenetic mutations, such as 
mutations in key players involved in the central regulation of energy homeostasis, such as the 
melanocortin 4 receptor (Mc4r), proopiomelanocortin (Pomc), or leptin (ob) genes result in 
drastic obese phenotypes, they can only be found in a minority of patients, and can therefore 
not be held accountable for the epidemic dimensions of obesity (Farooqi, 2008; Krude et al., 
1998; Montague et al., 1997; Santini et al., 2009). In contrast, complex polygenetic 
variations in combination with unfavorable environmental factors are thought to mainly 
contribute to the development of increased adiposity (Hetherington and Cecil, 2010). 
Importantly, the global shift to a more sedentary lifestyle and increased consumption of 
palatable, high-caloric, energy-dense food does not only increase an individual’s risk to 
develop obesity, but also augments the susceptibility for future generations. Multiple human 
epidemiological, as well as animal studies have demonstrated that children of obese mothers 
are more susceptible to eventually develop metabolic disorders themselves, a phenomenon 
that is often referred to as “metabolic programming” (see also Chapter 1.1.3) (for review, see 
(Sullivan and Grove, 2010)).  
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Thus, further efforts have to be made to unravel molecular mechanisms contributing 
to the development and manifestation of obesity to not only find novel therapeutic strategies, 
but also preventative measures to effectively intervene with the obesity epidemic, as well as 
its associated diseases.  
 
1.1.2  Type 2 diabetes mellitus 
As one of the main consequences of overweight and obesity, T2DM has also evolved into a 
global epidemic. In 2012, the international diabetes federation estimated the total number of 
patients with diabetes mellitus to be 382 million worldwide (Figure 1.1) (IDF, 2013). Of 
these 382 million, approximately 10 % account for patients diagnosed with Type 1 diabetes 
mellitus (T1DM) (IDF, 2013), which is characterized by chronic hyperglycemia caused by 
the complete loss, or highly impaired production of insulin, secondary to an autoimmune-
reaction-mediated destruction of pancreatic β-cells (WHO, 2013b). In contrast, T2DM is 
characterized by chronic hyperglycemia caused by the development of insulin resistance in 
peripheral organs, such as the muscle, white adipose tissue and the liver, as well as the central 
nervous system (CNS) (for review, see (Biddinger and Kahn, 2006)). As previously described, 
excessive caloric intake in combination with physical inactivity are the main reasons for the 
development of obesity, which is associated with chronic hyperglycemia. Under these 
pathological conditions, insulin is no longer able to efficiently stimulate glucose uptake into 
muscle and fat, and further fails to suppress hepatic glucose production, thereby additionally 
increasing blood glucose levels. Although hyperactivation of pancreatic β-cells is initially able 
to compensate for this insulin resistance, chronic hyperglycemia eventually leads to 
progressive deterioration of pancreatic β-cell function and finally, to exhaustion and loss of 
these cells, resulting in relative insulin deficiency in T2DM patients (Kahn et al., 1993; 
Polonsky et al., 1988; Prentki and Nolan, 2006).   
The T2DM-associated hyperglycemia can have tremendous effects on the function 
of multiple organs as it increases the risk for microvascular damage (i.e. retinopathy, 
nephropathy and neuropathy) (WHO, 2006). Moreover, T2DM is associated with an 
increased risk of macrovascular complications and, – if left untreated, or poorly controlled – 
can eventually lead to organ failure, ischemic heart disease or stroke (Vasudevan et al., 2006; 
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WHO, 2006). Therefore, despite the growing knowledge about cellular and molecular 
changes associated with T2DM, the ever-increasing incidences of T2DM highlight the 
necessity to decipher all underlying aspects contributing to the development and progression 
of this disease.  
 
 
1.1.3 Maternal obesity, maternal diabetes and the concept of metabolic programming 
Coincident with the ever-increasing cases of obesity and T2DM, the number of obese 
and/or diabetic women of childbearing age has reached an all-time high. Depending on the 
country and ethnicity of the cohort analyzed, studies estimate that currently 15-40% of 
pregnancies are affected by maternal obesity, and 3-10% of pregnancies by maternal diabetes 
(i.e. T1DM, T2DM and gestational diabetes) (Anna et al., 2008; Yu et al., 2013). This 
epidemic development has been a matter of great concern, because maternal obesity and 
diabetes have been associated with a multitude of adverse pregnancy outcomes, both for the 
mother and the child (Catalano and Ehrenberg, 2006; Dabelea et al., 2000; Torloni et al., 
2009a; Yu et al., 2013). 
 
1.1.3.1 Origin of the metabolic programming hypothesis  
The hypothesis that early life experience can determine the metabolic fate of an individual 
evolved as early as during the 1960s. Dubos and colleagues were the first to find a direct 
association between the nutritional content of maternal milk and the growth rate, as well as 
the lifelong efficacy of energy utilization of the offspring in mice (Dubos et al., 1966). In 
line with these results obtained in rodents, Ravelli and colleagues demonstrated that 
nutritional deprivation during distinct phases of pregnancy enhances the propensity to 
develop metabolic disorders during adulthood in humans. These findings demonstrated that 
metabolic programming occurs in response to hormonal insults during a critical time 
window of particular vulnerability: Exposure to the Dutch famine (which occurred in the 
winter of 1944-1945) during the first half of pregnancy significantly increased the rate of 
obesity later in life (Ravelli et al., 1976). In contrast, undernutrition during the third 
trimester of pregnancy decreased the rate of obesity, while at the same time increasing the 
incidences of insulin resistance and impaired glucose tolerance in adult men (Ravelli et al., 
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1998). In similar retrospective studies, David Barker and his colleagues found a negative 
correlation between birth weight (as an indicator of poor maternal nutrition during 
pregnancy) and the risk of developing cardiovascular, as well as metabolic diseases during 
adult life in an independent human cohort (Barker et al., 1993; Barker and Osmond, 1986; 
Barker et al., 1989; Hales et al., 1991).  
Although the ideas of latent health effects stemming from the perinatal period 
preceded the work of David Barker (Forsdahl, 1977; Ravelli et al., 1976), he is considered as 
one the pioneers of metabolic programming research. Based on his findings, David Barker 
postulated the “fetal and infant origin of adult disease” hypothesis (Barker, 1990) (later 
rephrased into “developmental origins of health and disease”) (Barker, 2007), which was 
further extended and modified by the “thrifty phenotype hypothesis” (Hales and Barker, 
1992, 2001), as well as the “developmental plasticity” (Barker, 2004) and “perinatal 
programming” theory ((Lucas, 1991), for review, see (McMillen and Robinson, 2005)). 
Together, these concepts suggest that environmental factors in response to maternal health 
and nutrition during a critical plastic phase of development trigger adaptive responses in the 
developing fetus, which result in persistent morphological modifications and altered 
sensitivity of organs involved in metabolic regulation. From an evolutionary perspective, 
these adaptations would enable a highly efficient use of metabolites and thereby increase the 
chances of survival in times of scarce food availability. However, upon an imbalance between 
the developmental and postnatal (nutritional) environment, these adaptations could prove 
detrimental, resulting in cardiovascular and/or metabolic diseases. These persistent 
developmental changes on the efficacy and tight control of metabolism in the offspring are 
often referred to as “metabolic programming”. However, underlying mechanisms of how 
metabolic programming might be mediated still remain largely elusive. 
 
 1.1.3.2 Adverse pregnancy outcomes in response to maternal obesity and diabetes 
Over the last decade, the main focus of metabolic programming research has expanded from 
studying undernutrition to also include deciphering the effects of over and/or malnutrition, 
as well as hyperglycemia during pregnancy on the future health of the offspring. Of note, 
studies analyzing the effects of maternal overnutrition on the offspring’s metabolic health 
found a similar link between elevated birth weight and an increased risk to develop 
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metabolic diseases as previously described for children born with low birth weight (Pettitt 
and Jovanovic, 2001). These findings highlight the crucial importance of a well-balanced 
hormonal and nutritional milieu for the developing fetus. In more recent studies, maternal 
BMI has replaced birth weight as an indicator for future health risks of the offspring. 
Prepregnancy BMIs above 25 have been shown to increase the risk for complications during 
pregnancy, such as pre-eclampsia, extreme pre-term deliveries and need for caesarean 
sections, thereby further augmenting the risk for the necessity of neonatal intensive care and 
possibly neonatal death (Cnattingius et al., 2013; Doherty et al., 2006; Kalk et al., 2009). 
Moreover, even under normal pregnancy progression, children of overweight and/or obese 
women have an increased risk to be large for gestational age (LGA) and are more likely to be 
born macrosomic (Yu et al., 2013). In turn, these neonatal abnormalities are associated with 
higher levels of obesity and T2DM during childhood that often persist throughout lifetime, 
possibly resulting in the development of certain co-morbidities including hypertension, 
coronary heart disease, or stroke (Ahlsson et al., 2007; Boney et al., 2005; Pham et al., 2013; 
Salsberry and Reagan, 2005; Whitaker, 2004).  
Apart from the direct effects of maternal adiposity on the offspring’s health, several 
studies clearly show a positive correlation between maternal BMI and the incidence of 
gestational diabetes mellitus (GDM) (Torloni et al., 2009b). GDM is defined as a state of 
glucose intolerance with onset or first recognition during pregnancy (WHO, 2013a). 
Importantly, GDM also develops in normal weight women and has been shown to increase 
the risk factors for adverse pregnancy outcomes independent of the maternal prepregnancy 
BMI or weight gain during pregnancy (Jovanovic-Peterson et al., 1991; Schaefer-Graf et al., 
2003). Thus, children born to diabetic mothers are more likely to be LGA, to be born with 
asymmetric macrosomia and to eventually develop obesity and T2DM irrespective of the 
maternal state of adiposity (Alberico et al., 2014; Dabelea and Pettitt, 2001; Schaefer-Graf et 
al., 2003; Silverman et al., 1998). However, dietary interventions in combination with well-
controlled physical exercise (and in some cases insulin therapy) have been proven to work 
effectively against the chronic hyperglycemia in GDM patients, thereby protecting the 
offspring from adverse pregnancy outcomes (Crowther et al., 2005). Nevertheless, even 
slightly elevated glucose levels during pregnancy, which are below the official criteria to be 
diagnosed with GDM, can lead to macrosomia, neonatal hyperinsulinemia and childhood 
obesity (Metzger et al., 2008) (Deierlein et al., 2011). Together, these findings demonstrate 
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the necessity to unravel the molecular and cellular changes not only in response to 
pathological maternal conditions such as obesity or diabetes during pregnancy, but also in 
response to slightly elevated levels of hormones and nutrients, such as insulin and glucose, 
predisposing for metabolic disorders throughout lifetime. In the search of the cause for this 
predisposition, hypothalamic neurocircuits regulating energy and glucose homeostasis have 
been identified as primary targets of metabolic programming, 
 
 
1.2 The role of the hypothalamus in the regulation of energy homeostasis 
  
The hypothesis that a stable internal environment even under changing external conditions 
is essential for the health and survival of an organism was originally suggested by the French 
Physiologist Claude Bernard and further developed to the definition of “homeostasis” by 
Walter B. Cannon (Cannon, 1929; Gross, 1998). Accordingly, energy homeostasis is 
defined as the equilibrium of energy intake (food consumption) and energy expenditure 
(basal and exercise-induced metabolic rate) (WHO, 2013c). Similarly, the term glucose 
homeostasis has been used to describe all processes involved in maintaining blood glucose 
concentrations at relatively stable levels. The detrimental effects of an imbalance in energy 
and glucose homeostasis are evident by the current obesity and T2DM epidemics 
responsible for a multitude of health complications and exploding health care costs.  
Whereas Claude Bernard suggested a significant role of the brain in the regulation of 
glucose homeostasis already in the middle of the 19th century, the notion of the central 
nervous system (CNS), specifically the hypothalamus, as being one of the most important 
regulators of energy homeostasis did not evolve until the beginning of the 20th century. 
Tumors in that particular brain region lead to hyperphagia, obesity and retarded puberty 
(known as the Babinski-Frohlich syndrome) (Bruch, 1993; Gross, 1998). Subsequent 
lesioning and electrical stimulation studies of distinct regions in the hypothalamus in rodents 
suggested the existence of specialized hypothalamic centers either mediating hunger, i.e. the 
lateral hypothalamic area (LH) or satiety, i.e. the arcuate nucleus of the hypothalamus 
(ARH), the ventromedial hypothalamus (VMH) and the paraventricular nucleus of the 
hypothalamus (PVH) (Anand and Brobeck, 1951; Gold, 1973; Hetherington and Ranson, 
1940). Although the functions of these hypothalamic areas are not as black and white as 
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initially thought, but more complex and intertwined, these experiments provided direct 
evidence that an intact hypothalamus was essential for maintaining energy homeostasis. 
Since then, a completely new field of research has emerged, dedicated to understanding the 
mechanisms underlying an impaired efficiency of hypothalamic neurocircuits in regulating 
energy and glucose homeostasis and thereby contributing to the development and 
manifestation of metabolic disorders. 
 
1.2.1  Structural organization of the hypothalamus 
As the key site in the CNS for the integration and translation of multiple biological signals, 
the hypothalamus has an array of unique features that enable the mediation of adaptive 
endocrine, autonomic and behavioral responses to maintain homeostasis: First, the 
hypothalamus displays an extensive structural complexity. Apart from its 11 major nuclei 
and compartmental areas, which are situated symmetrically around the third ventricle, the 
hypothalamus harbors several small nuclei as well as large fiber bundles (Figure 1.2) (Simerly, 
1995). Second, the hypothalamus, which occupies the ventral part of the diencephalon 
located beside the midbrain of the brainstem and below the thalamus, forms extensive 
bilateral neuronal connections within intra-, but also extra-hypothalamic sites (such as 
autonomic centers and the limbic system) (Hess, 1957; Simerly, 1995). Finally, its relative 
localization in the CNS adjacent to the third ventricle enables reciprocal communication 
with peripheral organs via blood-borne signals.  
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Figure 1.2: Schematic overview of the hypothalamus in the brain 
The hypothalamus is located beside the midbrain of the brainstem and below the thalamus. The 
major hypothalamic nuclei are situated symmetrically around the third ventricle above the median 
eminence. ME, median eminence; ARH, arcuate nucleus of the hypothalamus; VMH, ventromedial 
nucleus of the hypothalamus; DMH, dorsomedial nucleus of the hypothalamus; PVH, 
paraventricular nucleus of the hypothalamus; LH, lateral hypothalamic area; fx, fornix; 3V, third 
ventricle. 
 
 
With regard to energy homeostasis, the ARH has evolved as one of the most 
intensively studied regions in the CNS. The ARH resides at the mediobasal hypothalamus 
adjacent to the third ventricle and the median eminence (ME). The ME is defined as a 
circumventricular organ with high permeability for blood-borne signals due to its fenestrated 
capillaries, high vascularization and a “leaky” blood-brain barrier (Ciofi et al., 2009; 
Rodriguez et al., 2010). This unique location allows the ARH to integrate peripheral 
nutritional and hormonal signals, which reflect the energy status of the body, into neuronal 
responses to ultimately adapt behavior. At more rostral areas, the PVH resides in the 
periventricular zone at the dorsal end of the third ventricle. The main functions of the PVH 
are the regulation of pituitary hormones, as well as the modulation of the autonomic nervous 
system in response to changes in energy status (Figure 1.2) (Biag et al., 2012). Additionally, 
neurons of the VMH, an area that lies just above the ARH, have been established as crucial 
regulators of feeding behavior and glucose homeostasis, e.g. in the detection and counter-
regulation of hypoglycemia (Beverly et al., 1995; Levin et al., 2008). Residing dorsally of the 
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VMH, the dorsomedial hypothalamus (DMH) represents one of the main downstream 
target sites of neuronal projections from other hypothalamic nuclei and is therefore 
suggested to play an integrative role, for example as a relay center of ARH to PVH neuronal 
connections, thereby modulating appetite and emotional behavior (Chao et al., 2011; 
Thompson and Swanson, 1998). In contrast to the aforementioned hypothalamic nuclei, the 
LH is a loosely organized and heterogeneous zone that (as it name suggests) occupies most of 
the lateral area of the hypothalamus (Bernardis and Bellinger, 1993).  Moreover, as the 
most-intensively interconnected areas of the hypothalamus, the LH has not only been 
implicated in the regulation of energy and glucose homeostasis via endocrine and autonomic 
mechanisms, but has further been shown to modulate cognitive and skeletal motor functions 
(Bernardis and Bellinger, 1993; Cui et al., 2012).  
Although substantial progress has been made in unraveling the neuronal and 
hormonal circuits of these distinct hypothalamic nuclei controlling energy and glucose 
homeostasis, we are only starting to understand the complexity of their regulatory processes 
and how developmental and/or pathological insults may impair their efficiency to adapt 
energy balance to meet the prevailing demands of the organism.  
 
1.2.2 The Arcuate nucleus of the hypothalamus (ARH) 
1.2.2.1 ARH neuronal populations and the central melanocortin circuitry 
Two functionally antagonistic neuronal populations that reside in the ARH orchestrate 
transduction of peripheral nutritional and hormonal signals into behavioral responses: the 
anorexigenic proopiomelanocortin (POMC)-expressing and the orexigenic agouti-related 
peptide/neuropeptide Y (AgRP/NPY)-coexpressing neurons (for review, see (Butler, 2006)).  
To exert its anorexigenic effects, the pro-protein POMC has to undergo 
posttranslational modifications mediated by cell type-specific prohormone convertases 
resulting in the biologically active neurotransmitter α-melanocyte-stimulating-hormone (α-
MSH) (for review, see (Wardlaw, 2011)). Initially, POMC is endoproteolytically cleaved by 
the prohormone convertase 1/3 (PC1/3) into two main derivatives: the adrenocorticotropic 
hormone (ACTH) and β-lipotropin hormone (β-LPH), as well as a 16 kDa N-terminal 
fragment. In the hypothalamus, further processing of ACTH by PC2 yields a truncated form 
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of ACTH (ACTH1-17) and the corticotropin-like intermediate peptide (CLIP). Subsequently, 
carboxypeptidase E (CPE) endoproteolytically cleaves the C-terminal part of ACTH1-17, 
which is then amidated to form desacetyl α-MSH, the predominant form of α-MSH in the 
rodent hypothalamus. Moreover, PC2 and CPE further process β-LPH into β-MSH and the 
opioid peptide β-endorphin, as well as the N-terminal part of POMC into γ-MSH, 
neuropeptides that have also been implicated in the modulation of energy balance (for 
review, see (Wardlaw, 2011)). Accordingly, mutations resulting in impaired sorting or 
processing of POMC have been associated with the development of obesity, both in humans 
and rodents (Creemers et al., 2008; Jackson et al., 1997; Lloyd et al., 2006). 
Of note, POMC expression is not restricted to the ARH, but can also be found in 
extra-hypothalamic sites, such as the retina, spinal cord, the commissural part of the nucleus 
of the solitary tract (NTS) and the area postrema in the brainstem (Bronstein et al., 1992; 
Knigge et al., 1981; Lein et al., 2007). Moreover, POMC has critical functions in peripheral 
organs, including the pituitary and melanocytes of the skin, where it is essential for the 
production of ACTH and α-MSH-mediated hair follicle pigmentation, respectively 
(Bornstein and Chrousos, 1999; Rees, 2003). In contrast to POMC, AgRP can be 
modulated by, but does not depend on posttranslational modifications to exert its orexigenic 
effects, i.e. stimulation of feeding and inhibition of energy expenditure (Creemers et al., 
2006). Whereas AgRP expression in the CNS is restricted to the ARH, the co-expressed 
orexigenic NPY is one of the most abundant neuropeptides and widely expressed throughout 
the brain (Allen et al., 1983; Broberger et al., 1998; Minth et al., 1984; Sahu et al., 1988). 
Consistently, NPY is not only involved in the regulation of energy homeostasis, but has also 
been implicated in the control of blood pressure and circadian rhythm in an AgRP-
independent manner (Balasubramaniam, 1997).   
POMC and AgRP/NPY neurons form the basis of the so-called “central 
melanocortin system”, which is considered as one of the main neuronal circuits involved in 
the regulation of energy balance. Downstream neurons of the melanocortin system are 
defined by their expression of melanocortin receptors, a family of G-protein-coupled 
receptors (for review, see (Yang, 2011)). Although a total of five isoforms of the 
melanocortin receptors (MC1-5R) exist, only MC3Rs and MC4Rs are expressed in the brain, 
of which the MC4R seems to be the main isoform for the central melanocortin circuitry 
involved in the regulation of energy homeostasis (Cone, 2006; Yang, 2011). Second-order 
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neurons expressing the MC4Rs reside predominantly in the PVH, but can also be found in 
various other regions throughout the CNS (see Chapter 1.2.2.2 for further detail) (Balthasar 
et al., 2005; Warne and Xu, 2013). Upon feeding, binding of α-MSH to the MC4R 
stimulates neuronal activity, presumably by increasing intracellular cAMP levels in 
anorexigenic neurons in the PVH (Lee et al., 2001). However, in the fasted state, AgRP acts 
as an inverse agonist of the MC4Rs and prevents the anorectic effects mediated by α-MSH 
(Ollmann et al., 1997). In contrast to α-MSH and AgRP, NPY does not bind to MC4Rs, 
but inhibits the activity of MC4R-expressing neurons in the PVH by binding to NPYRs, a 
family of Gi/o-protein-coupled receptors, resulting in decreased cAMP levels (Gerald et al., 
1996). Moreover, AgRP/NPY neurons further mediate their orexigenic effects by synaptic 
release of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) directly onto 
neighboring POMC, as well as to other neurons throughout the CNS (see Chapter 1.2.2.2 
for further detail) (Cowley et al., 2001; Horvath et al., 1997). 
The importance of a functional central melanocortin system for maintaining energy 
homeostasis is supported by the fact that loss or mutations of POMC, MC3R, MC4R or 
ectopic expression of the MC3/4R antagonist Agouti in agouti viable yellow mutant mice 
(Avy) result in hyperphagia, obesity, hyperinsulinemia and hyperglycemia, both in rodents 
and in humans (Chen et al., 2000; Huszar et al., 1997; Lu et al., 1994; Smart et al., 2007; 
Yaswen et al., 1999). Additionally, acute intracerebroventricular (ICV) injection of α-MSH 
decreases, whereas ICV injections of AgRP and NPY stimulate food intake (Clark et al., 
1984; Millington et al., 2001; Rossi et al., 1998). However, genetic deletion of Agrp and/or 
Npy does not lead to any metabolic impairment and ablation of AgRP neurons early during 
neonatal development has only mild effects on body weight and feeding behavior, 
questioning the relative contributions of these orexigenic neurotransmitters in the regulation 
of energy homeostasis (Erickson et al., 1996; Luquet et al., 2005; Marsh et al., 1998; Qian 
et al., 2002). Nevertheless, acute ablation of AgRP neurons in adult mice induces extreme 
anorexia, eventually leading to starvation (Gropp et al., 2005; Luquet et al., 2005). These 
findings suggest that the central orexigenic feeding circuits remain highly plastic during 
development and that early loss of AgRP/NPY signaling can be compensated for by alternate 
signaling pathways to ensure survival of the organism. Importantly, specific restoration of 
GABA-signaling in one of the main extra-hypothalamic AgRP target sites, the parabrachial 
nucleus (PBN) of the brainstem, rescues the starvation phenotype in adult AgRP-ablated 
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mice (Wu et al., 2009). Thus, AgRP/NPY neurons of the ARH play a pivotal role in 
regulating energy homeostasis not only via modulation of MC4R-expressing neurons, but 
also via GABA-ergic signaling throughout the CNS (for review, see (Wu et al., 2009)).  
Taken together, central regulation of energy and glucose homeostasis depends upon 
a functional melanocortin circuitry, as well as melanocortin-independent ARH neuronal 
signaling to efficiently coordinate feeding behavior.  
 
1.2.2.2 Intra-and extra-hypothalamic ARH neuronal circuits 
To mediate central regulation of energy and glucose homeostasis, the ARH POMC and 
AgRP/NPY neurons project to various sites within the hypothalamus, such as the PVH, 
DMH and LH. In the PVH, α-MSH and AgRP directly act (among other neuronal 
populations) on anorexigenic MC4R-expressing neurons defined by their expression of 
either thyrotropin-releasing hormone (TRH) or corticotropin-releasing hormone (CRH), 
which regulate hormonal release from the pituitary. In contrast, the neuronal identity of 
ARH downstream neurons of the DMH and LH are not fully elucidated, yet.  However, it 
has been suggested that POMC and AgRP/NPY neurons modulate the activity of MC4R-
expressing GABA-ergic neurons in the DMH. Under conditions with increased energy 
demand or energy intake (e.g. during lactation or obesity), distinct neurons in the DMH 
express NPY, which are a direct target of MC4R-expressing GABA-ergig neurons of the 
DMH (Chen et al., 2004). These DMH NPY neurons in turn modulate the activity of 
anorexigenic PVH neurons, providing an additional, but indirect ARH neuronal circuit 
regulating feeding behavior. Similarly, MC4R-expressing neurons in the LH have been 
demonstrated to be GABA-ergic and to synapse onto the orexigenic orexin-expressing 
neurons implicated not only in the homeostatic, but also the hedonic modulation of food 
intake (Cui et al., 2012). In line with these findings, long-term blockage of MC4R-signaling 
by adeno-associated virus (AAV)-mediated expression of the MC4R antagonist Agouti in 
these distinct hypothalamic ARH neuronal target sites all resulted in robust, but differential 
effects on obesity development (Kas et al., 2004). Whereas Agouti expression in the PVH led 
to rapid hyperphagia and weight gain, Agouti expression in the DMH was associated with a 
delayed onset of increased food intake and body weight starting after approximately 6 weeks. 
Moreover, LH-specific inhibition of MC4R-signaling had no effect on feeding behavior 
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under normal condition, but augmented diet-induced obesity. Together, these findings 
demonstrate the complexity of ARH neuronal mediated regulation of energy homeostasis 
with distinct roles of MC4R-dependent POMC and AgRP neuronal signaling in different 
intra-hypothalamic nuclei that differentially impact on obesity development.  
 In addition to MC4R-dependent effects of POMC and AgRP neurons on energy 
balance via intra-hypothalamic target sites, these ARH neurons further modulate energy and 
glucose homeostasis by acting on brain regions implicated in the regulation of i) the 
autonomic nervous system, such as the dorsal vagal complex (DVC) in the brainstem and 
the intermediolateral nucleus (IML) in the spinal cord, ii) the reward circuitry, such as the 
amygdala, ventral tegmental area (VTA), nucleus accumbens and the bed nucleus of the stria 
terminalis (BNST) and iii) analgesia, such as the PBN, the periaqueductal grey (PAG) and 
dorsal raphe nucleus (Figure 1.3) (Betley et al., 2013; King and Hentges, 2011; O'Donohue 
et al., 1979). Of note, although there is a great convergence between the innervation pattern 
of POMC and AgRP/NPY axons throughout the CNS, not all target areas are innervated by 
both ARH neuronal populations to the same extent.  
Given the distinct functions of the aforementioned regions, they also diverge in their 
relative contribution in the POMC and AgRP/NPY-mediated regulation of energy balance. 
For example, while PVH- and amygdala-specific re-expression of the MC4R in an MC4R-
deficient background prevented approximately 60 % of obesity development due to 
complete restoration of food intake to wildtype levels, these mice still displayed a decrease in 
energy expenditure. In contrast, re-expression of the MC4R exclusively in the DVC and 
IML restored energy expenditure and glucose homeostasis without affecting food intake 
(Balthasar et al., 2005; Sohn et al., 2013). Thus, dissection of neuronal circuits emerging 
from the very well defined POMC and AgRP/NPY neurons of the ARH throughout the 
CNS revealed distinct cell-type and region-specific divergence in the relative contribution to 
regulate different aspects of energy and glucose homeostasis.   
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Figure 1.3: Schematic overview of ARH neuronal projections throughout the CNS  
POMC and AgRP/NPY neurons residing in the ARH project to various intra-hypothalamic (i.e. 
PVH, DMH, LH) nuclei, as well as to extra-hypothalamic target sites involved in the regulation of 
energy and glucose homeostasis, the control of the autonomic nervous system, the mesolimbic 
dopaminergic neurocircuitry and analgesia. POMC, proopiomelanocortin; AgRP, agouti-related 
peptide; NPY, neuropeptide Y; ARH, arcuate nucleus of the hypothalamus; BNST, bed nucleus of 
the stria terminalis; CEA, central nucleus of the amygdala; DMH, dorsomedial nucleus of the 
hypothalamus; DVC, dorsal vagal complex; IML, intermediolateral column; LH, lateral 
hypothalamic area; PAG, periaqueductal grey; PBN, parabrachial nucleus; PVH, paraventricular 
nucleus of the hypothalamus; PVT, paraventricular thalamic nucleus; VTA, ventral tegmental area.  
 
 
1.2.3 Hormonal signals regulating the melanocortin circuitry 
ARH-residing POMC and AgRP/NPY neurons act on their designated downstream neurons 
in response to hormonal and nutritional changes in the periphery. Here, the pancreas-
derived hormone insulin and the adipocyte-derived hormone leptin have been shown to be 
critically involved in conveying information about the current energy status and overall 
energy stores into centrally mediated adaptation of feeding behavior and metabolism (for 
review, see (Belgardt and Bruning, 2010)).  
 
1.2.3.1 Insulin signaling 
Insulin is secreted postprandially in response to elevated blood glucose levels from pancreatic 
β-cells. After meal-ingestion, glucose is imported into β-cells via glucose transporter (GLUT) 
2. Subsequent metabolism of glucose via glycolysis and the citric-acid cycle rapidly increases 
intracellular adenosine triphosphate (ATP) levels, which in turn leads to closure of ATP-
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sensitive potassium (KATP) channels and thus depolarization of the cell membrane. This 
depolarization opens voltage-gated Calcium (Ca2+) channels, thereby facilitating diffusion of 
Ca2+ into the cell, which triggers additional Ca2+ release from the endoplasmatic reticulum 
(ER) and finally insulin secretion into the blood stream (for review, see (Komatsu et al., 
2013)). 
Upon its secretion from pancreatic β-cells, insulin regulates various aspects of 
carbohydrate and lipid metabolism, e.g. insulin facilitates glucose uptake in muscle and 
adipose tissue, stimulates lipid and glycogen synthesis and suppresses hepatic glucose 
production (HGP), as well as lipolysis (Bluher et al., 2002; Bruning et al., 1998; Claycombe 
et al., 1998; Cross et al., 1995; Kershaw et al., 2006; Puigserver et al., 2003). Although these 
functions used to be primarily attributed to direct systemic effects of insulin, the CNS has 
emerged as a critical target site for insulin-mediated regulation of energy and glucose 
homeostasis, as well as reproduction (see chapter 1.2.3.3 for further detail). Insulin receptors 
(IR) are widely distributed throughout the CNS with marked regional variation in receptor 
density, showing the highest levels of expression in the hypothalamus, as well as in the 
olfactory bulb, cerebral cortex, cerebellum, hippocampus, thalamus and midbrain 
(Havrankova et al., 1978; van Houten et al., 1979). Insulin passes through the blood-brain 
barrier via a saturable, receptor-mediated process that yields insulin levels in the CNS 
proportional to plasma insulin (Baura et al., 1993). Identical to insulin signaling in the 
periphery, binding of insulin to its receptors in the CNS leads to rapid autophosphorylation 
of the IR and thereby to further activation of its intrinsic kinase activity, resulting in 
tyrosine-phosphorylation of insulin receptor substrate (IRS) proteins (for review, see 
(Biddinger and Kahn, 2006). Unlike in the periphery, where IRS-1 is essential for signal-
transduction, IRS-2 is the main mediator of insulin’s intracellular responses in the brain 
(Araki et al., 1994). Phosphorylated IRS-2 serves as a docking platform for proteins 
harboring a Src-homology (SH) domain, e.g. the p85 regulatory subunit of the 
phosphatidylinositide-3 kinase (PI3K). Subsequent phosphorylation of the membrane-
bound phosphatidyl-inositol-4,5-bisphosphate (PIP2) to phosphatidyl-inositol-3,4,5-
trisphosphate (PIP3) by the p110 catalytic subunit of PI3K results in a context-specific 
activation of several downstream molecules (for review, see (Cheatham and Kahn, 1995)). 
On the one hand, PIP3 activates KATP channels, leading to potassium outflow and thus, 
hyperpolarization and silencing of neurons (MacGregor et al., 2002; Plum et al., 2006). On 
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the other hand, PIP3 activates phosphoinositide-dependent kinase 1 (PDK1), which in turn 
phosphorylates and thus activates the kinase AKT to elicit downstream signaling events (for 
review, see (Vanhaesebroeck and Alessi, 2000)). Among other targets, AKT phosphorylates 
forkhead box-1 (FOXO-1), which results in nuclear-exclusion and thus inhibition of 
FOXO-1-mediated activation and/or repression of target genes (for review, see (Biddinger 
and Kahn, 2006)). Moreover, AKT phosphorylates the mammalian target of rapamycin 
(mTOR), a critical regulator of protein synthesis and inhibitor of autophagy (Figure 1.4B) 
(for review, see (Wullschleger et al., 2006)). Similar to insulin’s action in peripheral target 
tissues, insulin signaling in the brain mediates its variety of effects not only via PI3K, but 
also via the mitogen-activated protein (MAPK) signaling pathways (Figure 1.4 A). However, 
the role of IR-mediated activation of the MAPK-signaling in the regulation of energy 
homeostasis is less well defined so far.  
 
1.2.3.2 Leptin signaling 
In addition to insulin, central leptin action is critically involved in the regulation of energy 
and glucose homeostasis. As early as the 1950s, Gordon C. Kennedy postulated the lipostatic 
theory suggesting that a humoral signal produced by adipose tissue in direct proportion to 
fat mass could act on the hypothalamus to decrease food intake and increase energy 
expenditure (Kennedy, 1953). The brain would thereby monitor fat levels and maintain 
them at certain fix points. With the discovery of leptin in 1994, a hormone that is secreted 
in direct proportion to fat mass and acts in the brain to modulate energy and glucose 
metabolism, this humoral factor was identified and proved Kennedy’s theory correct in 
many aspects (Zhang et al., 1994).  
Leptin signals via the long form of its receptor (LepRb) to induce multiple 
intracellular signaling cascades, one of them being the JAK/STAT pathway. Upon leptin 
binding, the Janus kinase 2 (JAK2) is recruited to the receptor, where it autophosphorylates 
itself, as well as multiple tyrosine residues of the LepRb, which serve as binding sites for 
signal transducer and activator of transcription 3 (STAT3) proteins (Banks et al., 2000; 
Tartaglia, 1997). Subsequent JAK2-mediated phosphorylation of STAT3 leads to STAT3 
homodimerization, the exposure of its nuclear-localization domain and consequently to 
nuclear localization. In the nucleus, STAT3 serves as a transcription factor at various 
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promoter sites to regulate gene expression, e.g. upregulation of its own negative regulator 
suppressor of cytokine signaling 3 (SOCS3) (Bjorbaek et al., 1998). In addition to activating 
the JAK/STAT signaling cascade, leptin has also been described to signal via the PI3K 
pathway (Mirshamsi et al., 2004). Thus, the PI3K pathway resembles a point of convergence 
between insulin and leptin signaling. While studies have shown independent, as well as 
synergistic effects of insulin and leptin signaling in the regulation of energy and glucose 
homeostasis, we are only starting to understand the relative contribution of these hormones 
in adapting cellular and molecular processes in the CNS, to ultimately meet the immediate 
demands of the body.  
 
1.2.3.3 Insulin and leptin action on ARH neurons 
The notion that insulin acts in the brain to modulate feeding behavior has been 
demonstrated across species, as centrally administered insulin (either via ICV injection or 
intranasal application) decreases food intake, which is associated with loss of body weight in 
rodents, non-human primates and humans (Benedict et al., 2008; Woods et al., 1979; 
Zhang et al., 2008). Identical effects have been shown for central leptin injections, at least in 
rodents (Calapai et al., 1998; Schulz et al., 2012). Consistently, genetic deletion of the IR in 
the brain results in mild obesity, insulin resistance and infertility (Bruning et al., 2000); and 
neuron-specific LepRb ablation induces obesity and impaired neuroendocrine functions 
essential for energy and glucose homeostasis in mice (Cohen et al., 2001).  
To decipher the relative contribution of insulin and leptin action on ARH neurons 
in mediating these effects, studies have genetically ablated the IR and LepRb from these 
distinct neuronal populations. Surprisingly, specific deletion of the IR in either of these 
neuronal subtypes did not affect feeding behavior, or energy expenditure (Konner et al., 
2007). However, insulin-mediated suppression of HGP was blunted in mice lacking the IR 
specifically on AgRP neurons, demonstrating the role of central insulin in the regulation of 
glucose metabolism (Konner et al., 2007). In addition, specific reconstitution of the IR in 
AgRP neurons of L1 mice (mice that exclusively express the IR in liver, pancreatic cells and 
several regions in the brain, but which exhibit a 90 % reduction of IR expression in the 
ARH) further supported this finding. Here, HGP levels of L1 mice were restored to normal 
levels upon AgRP-specific reconstitution of the IR (Lin et al., 2010). By contrast, POMC-
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specific IR deletion had no effect on HGP (Konner et al., 2007). However, reconstitution of 
the IR in POMC neurons of L1 mice further exacerbated their hepatic insulin resistance, 
while at the same time restoring locomotor activity, suggesting a role for insulin signaling in 
POMC neurons in the regulation of energy expenditure (Lin et al., 2010). Similarly, LepRb 
deficiency in POMC or AgRP/NPY neurons had only mild effects on body weight gain and 
adiposity, which was slightly augmented upon LepRb ablation from both neuronal 
populations at the same time (van de Wall et al., 2008).  
Nonetheless, insulin and leptin have been shown to act via POMC and AgRP/NPY 
neurons to mediate central regulation of energy balance. On a molecular level, insulin and 
leptin are able to regulate Pomc, Agrp and Npy gene transcription. Whereas insulin increases 
POMC mRNA expression in a PI3K-dependent manner, upregulation of POMC mRNA 
expression via leptin depends on phosphorylation of STAT3 (pSTAT3) (Belgardt et al., 
2008; Xu et al., 2007). In contrast, both insulin and leptin decrease NPY and AgRP 
expression in a PI3K-dependent manner. Crucial for both of these effects is FOXO-1, which 
acts as a transcriptional repressor of Pomc by recruiting histone deacetylases, and as a 
transcriptional activator of Agrp and Npy, respectively (Kim et al., 2006; Kitamura et al., 
2006). Thus, in POMC neurons, PI3K-mediated phosphorylation and subsequent nuclear 
exclusion of FOXO-1 allows pSTAT3 to bind and induce Pomc transcription, whereas in 
AgRP/NPY neurons, PI3K-mediated phosphorylation of FOXO-1 indirectly inhibits Agrp 
and Npy expression, as subsequent nuclear exclusion allows for pSTAT3 to act as a 
transcriptional repressor of these orexigenic neuropeptides (Figure 1.4 B) (Fukuda et al., 
2008; Morrison et al., 2005).  
Moreover, insulin and leptin directly modulate the activity of both POMC and 
AgRP/NPY neurons. Central leptin administration depolarizes and thus increases POMC 
neuronal activity in a PI3K-dependent manner (presumably via transient receptor potential 
cation (TRPC) channels and, at the same time, hyperpolarizes and thus inhibits AgRP/NPY 
neurons by modulating KATP channel activity (Mirshamsi et al., 2004; Qiu et al., 2010; van 
den Top et al., 2004). Collectively, these changes in neuronal activity lead to an increased α-
MSH and decreased NPY synaptic release, thereby mediating anorexigenic behavior. Insulin 
on the other hand leads to a PI3K-dependent activation of KATP channels and thus 
hyperpolarization of both POMC and AgRP/NPY neurons (Figure 1.4 B) (Konner et al., 
2007; Plum et al., 2006). To date, this seemingly paradoxical situation, where insulin exerts 
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the same effect on neuronal activity of two functionally opposing neurons is not yet resolved. 
Moreover, the question arises how two “anorexigenic” hormones, i.e. insulin and leptin, 
which both require PI3K-mediated signaling cascades in POMC neurons to exert their 
functions, can result in opposite effects regarding the net outcome of POMC neuronal 
activity. Interestingly, insulin- and leptin-mediated changes in POMC neuronal activity 
occur in two distinct neuronal subpopulations (Williams et al., 2010). Furthermore, this 
segregation in POMC neuronal insulin and leptin responses show a neuroanatomical pattern, 
further supporting the existence of distinct POMC neuronal subpopulations. However, 
whether this selective responsiveness of POMC neurons to these differences in hormone 
sensitivity with regards to neuronal activity are due to 1) differential expression of their 
respective hormone receptors, 2) different ion channel distribution, 3) distinctive activation 
of specific signaling intermediates or 4) completely different mechanisms, remains to be 
elucidated.  
In contrast, such heterogeneity in terms of hormone-mediated changes in neuronal 
activity has not been described for AgRP neurons so far. However, a recent paper from 
Betley and colleagues investigated the efficacy of distinct AgRP/NPY neurocircuits to 
stimulate feeding in response to channelrhodopsin 2 (ChR2)-mediated AgRP neuronal 
activation (Betley et al., 2013). Here, they could show that distinct AgRP/NPY neuronal 
subgroups located in distinct areas of the ARH innervate only one specific target area. 
Moreover, neuronal activation of AgRP/NPY circuits only from ARH->PVH, ARH->LH 
and ARH->BNST were sufficient to induce rapid feeding, whereas optogenetic activation of 
AgRP/NPY circuits from ARH->PBN, ARH->CEA and ARH->PAG were not associated 
with changes in feeding behavior. Thus, similar to the specialization of POMC neurons in 
terms of hormone-responsiveness, AgRP/NPY neurons can be divided into subgroups 
depending on their relative topographic distribution and their specific downstream target 
area of innervation, as well as their relative contribution to regulate feeding behavior. The 
findings that discrete subgroups of defined neuronal populations of the ARH segregate not 
only in their sensitivity towards hormonal and nutritional changes, but also in their 
innervation pattern, as well as their relative contribution to mediate different aspects of 
metabolism, highlight the complexity of hypothalamic regulated energy and glucose balance. 
To further complicate matters, one hallmark of obesity is the development of insulin 
and leptin resistance not only in peripheral organs, such as liver, muscle and fat, but also in 
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the CNS. Thus, although insulin and leptin might be secreted in obese patients in response 
to glucose excursions and elevated fat mass, respectively, IR and LepRb-expressing target 
cells are incapable of converting these signals into adaptive behavioral and systemic 
metabolic changes. Thus, a better understanding of how cell-type specific central insulin and 
leptin signaling contribute to the regulation of energy and glucose homeostasis, in 
combination with a clearer picture of the mechanisms underlying hormonal resistance at the 
level of the CNS, is of utmost importance to develop effective therapeutics and preventative 
strategies in the fight against obesity.  
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Figure 1.4: Insulin and leptin signaling in POMC and AgRP/NPY neurons 
A) Binding of insulin to the insulin receptor (IR) results in a conformational change, activation of 
the membrane bound receptor tyrosine kinase and autophosphorylation of the IR. IRS2 is 
phosphorylated, binds to the p85-regulatory subunit of PI3K, leading to phosphorylation of PIP2 to 
PIP3 by the p110-catalytic domain of PI3K. PIP3 activates PDK1, which phosphorylates 
AKT,which activates several downstream signaling events, e.g. phosphorylation and nuclear exclusion 
of FOXO-1 and phosphorylation of mTOR. B) Insulin-mediated phosphorylation of FOXO-1 
allows leptin-mediated phosphorylated STAT3 to bind to the promoter of the Pomc, as well as Agrp 
and Npy gene, resulting in their upregulation and downregulation, respectively. Moreover, insulin 
activates KATP channels in POMC (red) and AgRP (green) neurons, resulting in their 
hyperpolarization, whereas leptin depolarizes POMC in a TRPC-dependent and hyperpolarizes 
AgRP neurons in a JAK2/PI3K-depenendent manner. PI3K, phosphatidylinositol 3 kinase; IRS2, 
insulin receptor substrate 2; PIP2, phosphatidylinositol (4,5) bisphosphate; PIP3, 
phosphatidylinositol (3,4,5) trisphosphate; PDK1, protein-dependent kinase 1; AKT, protein kinase 
B; mTOR, mammalian target of rapamycin; FOXO-1, forkhead box 1; JAK2, janus kinase 2; 
STAT3, signal transducer and activator of transcription 3; KATP, ATP-dependent potassium 
channel; TRPC, transient receptor potential cation channel; POMC, proopiomelanocortin; AgRP, 
agouti-related peptide; NPY, neuropeptide Y; P, phosphorylation; dashed lines indicate leptin-
mediated signaling. 
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1.3 The hypothalamus as a primary target site for metabolic programming 
 
Given its crucial role in the regulation of energy and glucose homeostasis, the hypothalamus 
has been in the focus as one of the main target sites for metabolic programming in offspring 
of obese, diabetic, hyperglycemic or malnourished mothers. Moreover, both mother and 
child are highly sensitive towards nutritional and/or hormonal changes during pregnancy 
and development, respectively. Thus, alterations in the nutritional environment in response 
to impaired maternal health or quality of food during pregnancy have been demonstrated to 
have a direct impact on hypothalamic neurocircuit development, which is associated with a 
lifelong predisposition for metabolic disorders in the offspring.   
 
1.3.1 Development of hypothalamic neurocircuits 
Hypothalamic neurocircuit development follows a specific pattern of events that can be 
roughly divided into two major phases: 1) Determination of neuronal cell number, which 
involves neurogenesis, neuronal death, neuronal differentiation and migration and 2) 
Formation of functional circuits, which includes axonal outgrowth and synaptogenesis (for 
review, see (Bouret, 2012)). Whereas the sequence of events is thought to be identical 
between rodents and humans, the relative timing is highly distinct between these species: 
Unlike in humans, where both of these phases occur in utero, axon formation and 
synaptogenesis of hypothalamic neurocircuits occur during the first three weeks after birth in 
rodents (Figure 1.5) (Grove et al., 2005; Koutcherov et al., 2002) .  
Hypothalamic neurons are generated predominantly in the neuroepithelium of the 
third ventricle. Extensive thymidine labeling and BrdU incorporation studies in the rodent 
could further pinpoint the period(s) of neurogenesis of distinct hypothalamic nuclei, which 
occurs in a rostral to caudal and lateral to medial pattern (thus, cells that have to migrate the 
farthest, are born the earliest) (Shimada and Nakamura, 1973). The peak of hypothalamic 
neurogenesis is considered to be E12, at which most LH neurons are born. Moreover, 
neurogenesis of PVH and DMH neurons extends from E12-E16 and that of ARH and 
VMH neurons from E12 to E17 (Ishii and Bouret, 2012; Padilla et al., 2010). Similarly, in 
non-human primates neurogenesis of distinct neuronal subgroups occurs in specific time 
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windows during the first trimester of gestation (Koutcherov et al., 2003). To date, little is 
known about the subsequent differentiation and migration processes of these newly 
generated neuronal progenitors. At least for the VMH, it has been described that neurons 
migrate along radial glial fibers to their final positions in the nucleus (Rakic et al., 1994). 
However, whether this holds true as a global hypothalamic neuronal migration pattern 
remains to be investigated.  
The second phase of hypothalamic neurocircuit development is not initiated until 
the neurons have reached their final target area. In rodents, axonal projections of POMC 
and AgRP/NPY neurons innervate distinct intra-hypothalamic target areas between 
postnatal day (P) 6 and P16 (Figure 1.5) (Bouret et al., 2004a). Moreover, ARH neuronal 
projections to the extra-hypothalamic BSTN are established between P12 and P18 (Bouret 
et al., 2004a). Subsequently, synaptic connections are established and possibly pruned again 
to form functional neurocircuits, processes that gradually mature from birth until adulthood. 
As depicted before, contrarily to rodents, in humans and non-human primates, AgRP/NPY 
innervation of target areas starts at the end of the second and continues until the end of the 
last trimester of gestation (Figure 1.5) (Grayson et al., 2006; Koutcherov et al., 2002). 
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Figure 1.5: Development of hypothalamic neurocircuits in rodents and humans  
The ontogeny of functional hypothalamic neurocircuits is composed of two major steps: 1) 
Determination of neuronal cell number (i.e. neurogenesis) directly followed by their differentiation 
and migration and 2) the formation of mature axonal projections that include axonal outgrowth and 
synaptogenesis. In rodents hypothalamic neurons originate from progenitor cells of the 
neuropithelium of the third ventricle that are generated between embryonic day 12 (E12) and E17 
depending on the area. In rodents, development of axonal projections from arcuate neurons occurs 
during the first weeks of life. Once arcuate projections reach their target neurons, they develop 
synaptic contact. Hypothalamic development occurs during gestation and lactation in rodents and is 
not mature before weaning, whereas in humans, the hypothalamus is relatively mature already at 
birth as neurogenesis and axonal outgrowth take place during the second and third trimester. ARH, 
arcuate nucleus of the hypothalamus; PVH, paraventricular nucleus of the hypothalamus; VMH, 
ventromedial nucleus of the hypothalamus; DMH, dorsomedial nucleus of the hypothalamus; LH, 
lateral hypothalamic area; E, embryonic day; P, postnatal day; 3V,third ventricle.  Adapted from 
Steculorum, Vogt and Brüning, 2013 (Steculorum et al., 2013). 
 
 
 
1.3.2 Different animal models of metabolic programming show defects in hypothalamic 
neurocircuit development 
Although several human epidemiological studies have convincingly demonstrated that 
maternal obesity and diabetes result in an increased propensity for the unborn child to 
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develop metabolic diseases, further investigations of underlying cellular and molecular 
mechanisms responsible for this predisposition have been difficult to perform due to obvious 
ethical reasons. Therefore, several different animal models have been established to mimic 
this pathophysiological state, and could show that impaired maternal health and/or nutrition 
is directly associated with changes in hypothalamic neurocircuit formation in the offspring 
(for review, see (Plagemann, 2012)). 
One of the most commonly used models to mimic maternal obesity is maternal 
HFD-feeding, which has repeatedly been shown to increase body weight and adiposity, as 
well as to impair insulin sensitivity and glucose tolerance in the offspring (Guo and Jen, 
1995; Gupta et al., 2009; Kirk et al., 2009; Sun et al., 2012). On a cellular level, exposure to 
maternal HFD during gestation and lactation increases hypothalamic neurogenesis and 
neuronal migration of predominantly orexigenic neurons in the offspring (Chang et al., 
2008). Moreover, several studies have reported altered hypothalamic gene expression of 
anorexigenic and orexigenic neuropeptides in response to maternal HFD-feeding. However, 
there have been inconsistencies between studies as to whether the hypothalamic 
neuropeptidergic profile shifts to a more orexigenic tone (potentially acting as a main driver 
of obesity development) or to a predominantly anorexigenic tone (possibly as a counter 
regulation) in offspring from mothers consistently fed a HFD throughout gestation and 
lactation (Beck et al., 2006; Chen et al., 2008; Gout et al., 2010; Gupta et al., 2009). In 
addition to affecting the prenatal phase of hypothalamic neurocircuit development, 
consistent maternal HFD-feeding throughout gestation and lactation also impairs 
AgRP/NPY neuronal projection formation to the PVH (Kirk et al., 2009). 
To investigate the effects of maternal hyperglycemia on hypothalamic neurocircuit 
development and health outcome of the offspring, studies have made use of the β-cell toxin 
streptozotocin. Although streptozotocin destroys pancreatic β-cells, which results in 
complete insulin deficiency and therefore represents a state of maternal T1DM rather than 
GDM or T2DM, subsequent maternal hyperglycemia has the desired effects of 
hyperglycemia and hyperinsulinemia in the offspring (Pitkin and Van Orden, 1974). Similar 
to maternal obesity, maternal hyperglycemia also impairs both phases of hypothalamic 
neurocircuit development in the offspring, potentially contributing to the increased body 
weight and insulin resistance observed throughout lifetime in the offspring. However, 
different studies have led to conflicting results: Whereas Plagemann and colleagues observe 
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an increase in orexigenic NPY neurons with no effects on POMC neuronal cell number, 
Steculorum et al. find an increased POMC neuronal cell number without changes in the 
total count of AgRP/NPY neurons (Plagemann et al., 1998; Steculorum and Bouret, 2011). 
The latter finding has been confirmed in a genetic model of maternal diabetes (Carmody et 
al., 2011). Moreover, Steculorum et al. find a consistent decrease of ARH neuronal fiber 
densities in the PVH, suggesting impaired ARH neuronal axon formation in response to 
maternal diabetes, possibly adding to the impaired regulation of energy and glucose 
homeostasis of the offspring later in life (Steculorum and Bouret, 2011). 
Taken together, different models of metabolic programming have concordantly 
shown that both major phases of hypothalamic neurocircuit development are impaired in 
response to maternal obesity and maternal hyperglycemia. However, given the differences in 
the effects on hypothalamic neurocircuit development, possibly due to differences in study 
design (in particular the use of different species, as well as duration and severity of 
environmental cues), the relative contribution of these hypothalamic developmental 
abnormalities in mediating the strong metabolic impairments in the offspring remains to be 
clarified.  
 
1.3.3 Hypothalamic insulin and leptin signaling in metabolic programming    
The crucial role of well-balanced hypothalamic leptin levels during hypothalamic 
neurocircuit development has been established in a series of outstanding studies (Bouret et 
al., 2004b; Bouyer and Simerly, 2013). Different models of metabolic programming lead to 
increased levels of leptin during lactation in the offspring, which has repeatedly been shown 
to induce central leptin resistance early in life (Kirk et al., 2009; Sun et al., 2012). Given the 
well-described axonotrophic effect of leptin on neurons of the ARH, particularly during a 
critical time window in the postnatal period, it is conceivable that impaired axon formation 
in response to neuronal leptin resistance results in impaired energy and glucose homeostasis 
(Bouret et al., 2004b). In addition, specific restoration of a distinct AgRP to PVH 
innervation pattern in response to intraperitoneal leptin injections during postnatal 
development partially rescues the drastically impaired metabolic phenotype of leptin-
deficient mice (Bouyer and Simerly, 2013). These findings highlight the impact of abnormal 
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leptin levels on hypothalamic neurocircuit development, which is associated with an 
increased propensity to develop metabolic disorders in life. 
In contrast, the role of abnormal insulin signaling during development in mediating 
metabolic programming is less well described so far. Insulin has been shown to exert 
neuroproliferative and axonotrophic effects, at least in vitro (Desai et al., 2011; Schechter et 
al., 1999; Toran-Allerand et al., 1988). Moreover, elevated hypothalamic insulin levels have 
been detected in newborn offspring of diabetic mothers in rats (Plagemann et al., 1998). 
Therefore, developmental hyperinsulinemia in response to maternal glucose excursions 
either as a result of maternal obesity, diabetes or postnatal overnutrition has been 
hypothesized to exert detrimental effects on hypothalamic neurocircuit formation.  As 
depicted before, maternal diabetes affects hypothalamic neuronal cell number, as well as 
axon formation in the offspring. Of note, the observed architectural differences in the 
hypothalamus, i.e. decreased size of VMH and PVH, as well as upregulated levels of tyrosin-
hydroxylase (TH)-expressing neurons in offspring of STZ-treated dams were abolished upon 
adaptation of insulin and glucose levels in the mother, pointing to a distinct role of these 
hormones in mediating these effects (Franke et al., 2005; Plagemann et al., 1999a). 
Moreover, in a well controlled, but non-physiological experimental setup, early postnatal 
hypothalamic administration of insulin in neonatal rats resulted in malformations of distinct 
hypothalamic nuclei, i.e. VMH and DMH, possibly contributing to the observed 
impairment of body weight regulation and glucose tolerance in the offspring (Plagemann et 
al., 1999c; Plagemann et al., 1992). Nonetheless, although there is growing evidence that 
substantiates the hypothesis that early-life hyperinsulinemia impairs hypothalamic 
neurocircuit development and thereby contributes to the predisposition for metabolic 
disorders in offspring of obese/diabetic mothers, to date there is no direct proof that insulin 
is responsible for these changes or mechanistic evidence of how insulin might mediate these 
effects in vivo.  
 
1.4 Objectives 
 
Obesity and type 2 diabetes mellitus (T2DM) still represent two of the major health burdens 
of our society today. Indeed, despite ongoing extensive research performed to decipher all 
aspects contributing to the development and manifestation of these epidemics and ultimately 
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to find effective therapies, the incidences of obesity and T2DM are still rising and 
increasingly affect people at younger ages (Sabin and Shield, 2008).  
The concept of maternal or metabolic programming has received particular attention 
as one important contributing factor for this on-going trend: Women with altered metabolic 
homeostasis (e.g. as a result of overnutrition or hyperglycemia) during pregnancy are at 
increased risk to deliver children that are more prone to develop obesity, diabetes mellitus or 
cardiovascular diseases later in life, creating a futile cycle of metabolic disorder development 
(Sullivan and Grove, 2010). Given its crucial role in the regulation of energy and glucose 
homeostasis and its sensitivity towards environmental changes during development, the 
CNS, in particular the hypothalamus has evolved as one of the main target sites primarily 
affected in offspring of obese and/or hyperglycemic mothers. However, although various 
different mechanisms have been proposed to contribute to this metabolic programming, 
differences in study design, in particular in severity, duration and onset of abnormal 
environmental cues has led to different and even conflicting results, making it challenging to 
perform cross-comparisons between studies. Moreover, only a few studies could 
convincingly demonstrate that the observed malformations of hypothalamic neurocircuits in 
response to impaired maternal health or nutrition were directly associated with the impaired 
metabolic phenotype in the offspring throughout lifetime.  
Thus, to shed new light on these matters, we aimed to establish a physiological and 
well-controlled mouse model of metabolic programming that would allow us to identify the 
most sensitive period of hypothalamic neurocircuit development in response to maternal 
high fat feeding. Importantly, we further employed this model to delineate the distinct role 
of neuron-specific insulin signaling in causing the lifelong predisposition for metabolic 
disorders in the offspring of obese and/or hyperglycemic mothers.  
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2 Materials and methods 
2.1 Chemicals and biological material 
Size markers for agarose gel electrophoresis (Gene Ruler DNA ladder mix) were obtained 
from Thermo Fisher Scientific, Inc., Germany. Solutions were prepared with double-
distilled water (ddH2O).  
All chemicals and biological material used for this work are listed in table 2.1.1. 
 
Table 2.1.1 Chemicals and enzymes used in this study 
 
Chemical/Enzyme Supplier (Company, Country) 
0.9 % Sodium Chloride   Delta Select, Germany 
Acetic Acid Merck, Germany 
Acetone KMF Laborchemie, Germany 
Actrapid® (Insulin) Novo Nordisk, Denmark 
Agarose (Ultra Pure) Invitrogen, Germany 
Avidin Biotin Complex-Vectastain Kit Vector, USA 
Bacillol Bode Chemie, Germany 
Calcium Chloride Merck, Germany 
Desoxy-ribonucleotide-triphosphate  Amersham, Germany 
di-Sodiumhydrogenphosphate Merck, Germany 
Diaminobenzidin (DAB) Dako, Germany 
DNase, RNase-free Qiagen, Germany 
DPP4 Inhibitor Merck Millipore, Germany 
DreamTaq DNA Polymerase Thermo Fisher Scientific, Inc., Germany 
Ethanol, absolute Roth, Germany 
Ethidium bromide Applichem, Germany 
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Chemical/Enzyme Supplier (Company, Country) 
Ethylendiamine tetraacetate (EDTA) AppliChem, Germany 
EuroScript Reverse Transcriptase Eurogentec, Belgium 
Glucose 20% Delta Select, Germany 
Glycine Applichem, Germany 
HEPES Applichem, Germany 
Hydrochloride Acid (37 %) KMF Laborchemie, Germany 
Hydrogen Peroxide Sigma-Aldrich, Germany 
Isopropanol (2-Propanol) Roth, Germany 
Kaisers Glycerin Gelatine Merck, Germany 
L-Arginine Sigma-Aldrich, Germany 
Magnesium Chloride Merck, Germany 
Nitrogen (liquid) Linde, Germany 
Octenisept Schüle & Mayr, Germany 
Paraformaldehyde (PFA) Fluka, Sigma-Aldrich, Germany 
Potassium Chloride Merck, Germany 
Potassium Hydroxide Merck, Germany 
Proteinase K Roche, Germany 
Sodium Acetate AppliChem, Germany 
Sodium Chloride AppliChem, Germany 
Sodium Hydroxide Applichem, Germany 
Sodium-dihydrogenphosphate Sigma-Aldrich, Germany 
Sodium tetraborate decahydrate Sigma-Aldrich, Germany 
Sucrose Sigma-Aldrich, Germany 
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Chemical/Enzyme Supplier (Company, Country) 
Tissue Freezing Medium Jung, Germany 
Trishydroxymethylaminomethane  AppliChem, Germany 
Triton X-100 AppliChem, Germany 
Vectashield® Mounting Medium (DAPI) Vector, USA 
β-Mercaptoethanol GIBCO (Invitrogen), UK 
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2.2 Molecular biology 
2.2.1 Isolation of genomic DNA 
Genomic DNA was isolated from tail-biopsies obtained between P14 and P20. Briefly, the 
samples were incubated overnight in Tail Lysis Buffer (10 mM Tris-HCl, pH 8.0; 10 mM 
EDTA, pH 8.0; 150 mM NaCl; 0.2 % (w/v) SDS) containing 1 % Proteinase K (Roche, 
Germany) at 56°C. DNA was precipitated by adding an equal volume of isopropanol, mixed 
and pelleted by centrifugation. Subsequently, the DNA was washed with 70 % (v/v) Ethanol, 
dried at RT and resuspended in H2O.  
 
2.2.2 Quantification of nucleic acids 
Nucleic acid concentration was assessed by measuring the sample absorption at 260 nm with 
a NanoDrop® ND-1000 UV-Vis Spectrophotometer (Peqlab, Germany). The 260/280 nm 
absorbance ratio was used as a measure of purity of nucleic acid samples. Ratios of 
approximately 1.8 and 2.0 were accepted as pure DNA and pure RNA, respectively. 
 
2.2.3 PCR for genotyping 
Genotyping was performed by PCR (Mullis and Faloona, 1987; Saiki et al., 1988)  with 
customized primers (purchased from Eurogentec, Germany) listed in table 2.2.1. Reactions 
were performed in a Thermocycler iCycler PCR machine (Bio-Rad, Germany). All 
amplifications were performed in a total reaction volume of 25 µl containing a minimum of 
50 ng DNA template, 25 pmol of each primer, 25 µM dNTP Mix (Genaxxon BioScience, 
Germany), 10 x DreamTaq reaction buffer (Thermo Fisher Scientific, Inc., Germany) and 1 
unit of DreamTaq Polymerase (Thermo Fisher Scientific, Inc., Germany).  Amplified DNA 
fragments were analyzed on 2 % (w/v) agarose (Sigma, Germany) gels (1 x TAE, 0.5 mg /ml 
ethidium bromide), which were electrophoresed at 120 mV.  
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Table 2.2.1 Oligonucleotides used for genotyping 
All primer sequences are displayed in 5’-3’ order. Primer orientation is designated “sense” when 
coinciding with transcriptional direction 
 
Primer Sequence (5’-3’) Annealing site Orientation 
POMCCre-5’ (N16R) TGGCTCAATGTCCTTCCTGG Pomc promoter sense 
POMCCre-3’ (N57R) CACATAAGCTGCATCGTTAAG endogenous Pomc antisense 
POMC-Cre-3’ (AA03) GAGATATCTTTAACCCTGATC Cre antisense 
AgRPCre-5’ GGGCCCTAAGTTGAGTTTTCCT Agrp sense 
AgRPCre-3’ GATTACCCAACCTGGGCAGAAC Agrp antisense 
AgRPCre-3’ GGGTCGCTACAGACGTTGTTTG mutant Agrp antisense 
IR-5’ CTGAATAGCTGAGACCACAG Insr floxed exon sense 
IR-delta-5’ GATGTGCACCCCATGTCTG Insr deletion sense 
IR-3’ GGGTAGGAAACAGGATGG Insr floxed exon antisense 
POMC-eGFP1-5’ TGGCTCAATGTCCTTCCTGG Pomc promoter sense 
POMC-eGFP2-3’ CACATAAGCTGCATCGTTAAG endogenous Pomc antisense 
POMC-eGFP3-3’ 
CAGGAACTCCAGCAGGACCATG eGFP antisense 
tdTomato1-5’ 
AAGGGAGCTGCAGTGGAGTA Rosa26 sense 
tdTomato2-5’ 
CTGTTCCTGTACGGCATGG mutant Rosa26 sense 
tdTomato3-3’ 
CCGAAAATCTGTGGGAAGTC Rosa26 antisense 
tdTomato4-3’ GGCATTAAAGCAGCGTATCC mutant Rosa26 antisense 
    
2.2.4 Analysis of gene expression 
Hypothalami were dissected using Brain Matrices (Braintree Scientific, Inc, USA). Isolated 
mRNA from this tissue was analyzed using quantitative real-time PCR. RNA was isolated 
using the Qiagen RNeasy Kit (Qiagen, Germany), which was combined with the RNase-
Free DNase Set (Qiagen, Germany). RNA was reversely transcribed with High Capacity 
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cDNA RT Kit and amplified using TaqMan® Universal PCR-Master Mix, NO AmpErase 
UNG with TaqMan® Assay-on-demand kits (Applied Biosystems, USA; see Table 2.2.2) 
with the exception of the POMC mRNA: POMC sense 5’-
GACACGTGGAAGATGCCGAG-3’; POMC antisense 5’-
CAGCGAGAGGTCGAGTTTGC-3’; probe sequence, 5’-FAM-
CAACCTGCTGGCTTGCATCCGG_TAMRA-3’. Relative expression of target mRNAs 
was adjusted for total RNA content by hypoxanthine guanine phosphoribosyl transferase 1 
(Hprt1) RNA. Calculations were performed by a comparative method (2-ΔΔCT). Quantitative 
PCR was performed on an ABI-PRISM 7900 HT Sequence Detection system (Applied 
Biosystems, USA).  
 
Table 2.2.2: Probes used for quantitative real-time PCR 
All probes were purchased from Applied Biosystems, USA 
 
Probe Catalogue N° 
Hprt-1 Mm01545399_m1 
Pomc Mm00435874_m1 
Agrp Mm00475829_g1 
Npy Mm00445771_m1 
Trh Mm01182425_g1 
Tnf Mm00443258_m1 
Il6 Mm00446190_m1 
Il1b Mm01336189_m1 
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2.3 Cellular biology 
2.3.1 Immunohistochemistry 
2.3.1.1 POMC and AgRP neuronal cell count 
POMCeGFP and AgRPtdTomato mice were transcardially perfused with phosphate buffered saline 
(PBS), pH 7.5, followed by 4 % paraformaldehyde (PFA) in PBS, pH 7.5. Brains were 
dissected, postfixed for 4 h at 4°C in PBS containing 4% PFA and 20% Sucrose, pH 7.5 and 
cryoprotected overnight in PBS containing 20% Sucrose, pH 7.5. To determine neuronal 
cell number, 25 µm-thick free-floating coronal sections through the ARH were cut using a 
cryostat (Leica, Germany) and used for the respective staining. GFP-positive neurons were 
detected as previously described (Janoschek et al., 2007). Briefly, sections were incubated in 
rabbit anti-GFP antiserum (1:10000, Molecular Probes/Invitrogen). Incubation with 
secondary Biotin-labeled donkey antirabbit IgG (1:500, Jackson ImmunoResearch) was 
followed by incubation with the VECTASTAIN Elite ABC kit (Vector Laboratories) and 
0.4 % DAB/0.01 % H2O2 for 1 h. Pictures were acquired using a Leica DM1000 LED 
microscope (Leica, Germany) equipped with a 10x objective. Pictures of red fluorescent 
protein in AgRP neurons were acquired using a confocal Leica TCS SP-8-X microscope 
(Leica, Germany) equipped with a 20x objective. For each animal, neurons were manually 
counted to obtain the total POMCeGFP and/or AgRPtdTomato neuronal number.  
 
2.3.1.2 α-MSH and AgRP immunostaining  
8- and 20-week-old male mice were anesthetized and transcardially perfused with phosphate 
buffered saline (PBS), pH 7.5, followed by 4 % paraformaldehyde (PFA) in borate buffer, 
pH 9.5 and post-fixed for 4 h in 20 % sucrose 4 % PFA in borate buffer and transferred to 
20 % sucrose in PBS overnight. Brains were frozen, sectioned at 25 µm and processed for 
immunofluorescence as previously described (Bouret et al., 2004b; Bouret et al., 2008; 
Steculorum and Bouret, 2011). Briefly, sections were incubated in goat anti-AgRP (1:4000; 
Phoenix Pharmaceuticals) or sheep anti-α-MSH (1:20000, Millipore). Secondary Alexa 
Fluor 488 goat antirabbit IgG or Alexa Fluor 568 donkey anti-sheep IgG (1:200, Life 
Technologies™) were used to detect primary antibodies. Sections were mounted in DAPI-
containing Vectashield (Vector Laboraties Inc.). Sections were only used for quantification if 
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the region could be unequivocally identified. Pictures were acquired using a confocal Leica 
TCS SP-8-X microscope equipped with a 20x objective (Leica, Germany). Image analysis 
was performed in a blind manner using ImageJ software (ImageJ1.45s; National Institutes of 
Health, USA), as previously described (Bouret et al., 2004b; Steculorum and Bouret, 2011). 
Briefly, the integrated density was calculated for each image, a figure that reflects the total 
number of pixels in a given region of the image and that is proportional to the total density 
of labeled fibers in this region (for a step-by-step illustration of the quantification process, 
please see Figure 2.3.1). If there were more than one section per animal in the correct region, 
the average integrated intensity was used to calculate the ratio to the average integrated 
density of control animals (i.e. NCD/NCD ctrl), which was used for further statistical 
analyses.  
 
Figure 2.3.1 Representative step-by-step 
quantification of α-MSH and AgRP 
immunostaining 
Pictures were quantified using the Image J software. A) 
Raw pictures were imported and B) transformed into 
16-bit images and subsequently binarized. C) The 
thresholds of each image were adjusted to highlight 
specific staining. D) The integrated density from each 
picture was determined from a region of interest that 
represented the respective brain region of interest (here 
the anterior paraventricular nucleus of the 
hypothalamus). Agouti-related peptide (AgRP) 
immunostaining in green. The red box indicates area 
of quantification. 
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2.3.1.3 Insulin and vAChT fluorescent double-immunostaining 
Frozen pancreata were sectioned at 10 µm at three different levels, collected on microscope 
slides and frozen at -20°C until further use. Microscope slides were warmed up to room 
temperature (RT) for 20 mins and fixed with 4 % PFA in PBS, pH 7.5 for 10 minutes. The 
slides were then rinsed in PBS and subjected to antigen retrieval. For this, 500 ml 1x Citrate 
Buffer (10 mM Citric Acid in ddH2O, pH=6.0) were preheated in Tupperware (without lid 
and without slides) for 1 min at 900 W in a microwave. Subsequently, the slides were placed 
in a glass holder and put into the preheated solution (slides must be well covered with 
liquid) and heated for 5 mins at 900 W, 5 mins at 600 W and 10 mins at 360 W without lid. 
Slides cooled down slowly in the solution for 30 mins at RT and were subsequently washed 
twice in PBS for 5mins each.  Pancreatic sections were then blocked in PBS containing 3% 
donkey serum and 0.3 % Triton X (Sigma) for 1 h at RT and subsequently incubated in 
goat anti-vACht (1:100, Millipore) and guinea-pig anti-Insulin (1:500, Dako) in PBS 
containing 3 % donkey serum and 0.3 % Triton X overnight at RT. Primary antibodies 
were detected with Alexa Fluor488 donkey anti-goat IgG (1:500, Life Technologies™, USA) 
and Cy3 donkey anti-guinea-pig (1:500, Jackson ImmunoResearch Laboratories, Inc., USA) 
for 1 h at RT. 10-15 islets per animal were acquired using a confocal Leica TCS SP-8-X 
microscope equipped with a 40x objective. Image analysis was performed using ImageJ 
software (ImageJ1.45s; National Institutes of Health, USA). Briefly, each vAChT-
immunoreactive button that could clearly be distinguished from background signal was 
counted and set in relation to the insulin-immunoreactive islet size. The average relative 
number of vAChT-immunoreactive buttons of all islets from one animal was used to 
calculate its ratio to the average number of the relative vAChT-immunoreactive buttons of 
ctrl animals (i.e. NCD/NCD ctrl), which was used for further statistical analyses.  
 
2.3.1.4 Analysis of pancreatic β-cell mass 
Pancreatic sections were fixed with acetone for 10 minutes at 4°C. Subsequently, sections 
were first blocked in PBS containing 1 % BSA and 0.3 % H2O2 and, after washing 3x with 
PBS, blocked in Rotiblock (1:10 with PBS, Roth®, Germany) containing 0.1 % Triton X. 
Incubation with guinea pig anti-insulin (1:50, DAKO, Germany) for 60 minutes was 
followed by 3x washing with PBS and 60 minutes incubation with secondary horse-radish 
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peroxidase (HRP)-coupled anti-guinea-pig (HRP; 1:500, Jackson ImmunoResearch 
Laboratories, Inc., USA) in PBS containing 0.25 % Triton X. HRP was detected using 
liquid diaminobenzidine + chromogene Substrate (1:50, Dako) for 20 minutes. Sections 
were counter-stained with Mayer’s Haematoxylin for 3 minutes. Pictures were acquired 
using the LeicaSCN400 slidescanner for brightfield images equipped with a 20x objective 
(Leica, Germany).  For quantification, the size of the each islet per pancreatic section was 
determined using Image J (ImageJ1.45s; National Institute of Health, USA) and the average 
islet size, the total number of islets and β-cell mass in relation to overall size of the pancreatic 
section was calculated. 
 
2.3.2 Electrophysiology 
All electrophysiological experiments were performed by Dr. Lars Paeger, Dr. Simon Hess 
and Dr. Andreas Pippow from the laboratory of Prof. Dr. Kloppenburg from the Biocenter, 
Institute for Zoology, University of Cologne, Germany. POMC neurons were recorded 
from NCD/NCD and NCD/HFD POMCeGFP transgenic mice (Cowley et al., 2001) at 
room temperature (RT) under current- and voltage-clamp in the perforated patch and 
whole-cell patch-clamp configuration using an EPC10 patch-clamp amplifier (HEKA). The 
animals were anesthetized with halothane (B4388; Sigma-Aldrich, Germany) and 
decapitated. Coronal slices (250 – 300 µm) containing the arcuate nucleus (ARH) were cut 
with a vibration microtome (HM-650 V; Thermo Scientific, USA) under cold (4°C), 
carbogenated  (95% O2 and 5% CO2), glycerol-based modified artificial cerebrospinal fluid 
(GaCSF; (Ye et al., 2006)), which contained (in mM): 250 Glycerol, 2.5 KCl, 2 MgCl2, 2 
CaCl2, 1.2 NaH2PO4, 10 HEPES, 21 NaHCO3, and 5 Glucose adjusted to pH 7.2 with 
NaOH. If not mentioned otherwise, the brain slices were continuously superfused with 
carbogenated artificial cerebrospinal fluid (aCSF) at a flow rate of ~2 ml·min-1, which 
contained (in mM): 125 NaCl, 2.5 KCl, 2 MgCl2, 2 CaCl2, 1.2 NaH2PO4, 21 NaHCO3, 10 
HEPES, and 5 Glucose adjusted to pH 7.2 with NaOH.  
Current-clamp recordings in the perforated patch configuration were performed using 
protocols modified from Horn and Marty (Horn and Marty, 1988), Rae et al. (Rae et al., 
1991) and Akaike and Harata (Akaike and Harata, 1994). The recordings were performed 
with ATP and GTP free pipette solution containing (in mM): 128 K-gluconate, 10 KCl, 10 
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HEPES, 0.1 EGTA, 2 MgCl2 and adjusted to pH 7.3 with KOH. The patch pipette was tip 
filled with internal solution and back filled with tetraethylrhodamine-dextran (D3308; 
Invitrogen, Eugene, OR, USA) and amphotericin B- (~200 µg·ml-1; A4888; Sigma) or 
nystatin-containing (~200 µg·ml-1; N6261; Sigma) internal solution to achieve perforated 
patch recordings. For the mean firing rate of POMC neurons, the measured frequency was 
averaged as soon as it was stable for ~5 mins after perforation reached stable series resistances. 
Cell input resistance and whole-cell conductance were calculated from voltage responses to 
hyperpolarizing current pulses.  
Whole-cell recordings were performed following the methods of Hamill et al. (Hamill et al., 
1981). For measurements of postsynaptic currents (PSCs), the patch pipette solution 
contained (in mM): 140 KCl, 10 HEPES, 0.1 EGTA, 5 MgCl2, 5 K-ATP, 0.3 Na-GTP; 
adjusted to pH 7.3 with KOH). Cells were voltage clamped at -60 mV and the high 
intracellular chloride concentration shifted the chloride equilibrium potential to a more 
depolarized potential, which reversed the polarity of GABAA receptor mediated currents 
from outward to inward, and made their detection easier by increasing the driving force on 
the chloride ions. The contribution of excitatory (EPSCs) and inhibitory PSCs (IPSCs) to 
the synaptic input was determined in three steps. First, we measured the overall frequency of 
PSCs. Second, we blocked the glutamatergic EPSCs with 5 x 10-5 D-AP5 and 10-5 M CNQX 
to isolate the IPSCs, which were identified as GABAergic (inhibitory) PSCs by their 
sensitivity to 10-4 M PTX. The EPSC frequency was determined by subtracting the IPSC 
frequency from the overall frequency. The overall PSC frequency was determined after the 
recording had stabilized (>10 minutes after break in) for a 2 minutes interval. The IPSC 
frequency was measured after 10 – 15 minutes D-AP5/CNQX application for a 2 minutes 
interval. Ratios of IPSCs are relative to overall PSCs.  
 
 
2.4 Biochemistry 
2.4.1 Enzyme-linked immunosorbent assays (ELISA) 
Serum insulin, leptin, C-peptide and GLP-1 levels were measured by enzyme-linked 
immunosorbent assays according to the manufacturer’s instructions (Mouse/Rat Insulin 
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ELISA, Mouse Leptin ELISA, Crystal Chem Inc., USA; Mouse C-peptide (Mouse) ELISA 
Kit, ALPCO, USA; GLP-1 ELISA kit, MyBioSource, USA). 
 
2.4.2 MALDI-TOF mass spectrometry 
The ARH were carefully microdissected under visual guidance using a binocular microscope, 
then rinsed in distilled water for a few seconds and transferred with a glass capillary into 20 
µl methanol/water (1/1) in 1 % formic acid. All following steps were performed by Dr. 
Susanne Neupert from the laboratory of Prof. Dr. Predel from the Biocenter, Institute for 
Zoology, University of Cologne, Germany. Dissected tissues were homogenized, sonicated 
and subsequently centrifuged for 15 min at 13.000 U/min. All steps were performed at 4°C; 
0.3µl of the supernatant was pipetted on a stainless steel sample plate for MALDI-TOF mass 
spectrometry. Remaining supernatants were each filled with 40 µl 0.5 % acetic acid and then 
evaporated to about 10 µl to reduce the methanol concentration. Samples were refilled, 
again with 40 µl 0.5 % acetic acid, and loaded onto activated and equilibrated home-made 
Stage Tips (Rappsilber et al., 2007) filled with C18 discs from EmporeTM filter material 
(Bioanalytical Technologies). After rinsing with 20 µl 0.5 % acetic acid, peptides were eluted 
using 4 µl of 10/20/25/30/40/50 % acetonitrile in 0.5 % acetic acid, respectively. Each 
eluate was divided in six portions and applied onto the sample plate for MALDI-TOF mass 
spectrometry. Dried samples were covered with a mixture of 0.5 µl α-cyano-4-
hydroxycinnamic acid (CHCA, Sigma-Aldrich) dissolved in 50% methanol/water. After 
drying at room temperature, each spot was finally rinsed with water for a few seconds. Mass 
spectra were manually acquired in positive ion and reflectron mode on an ultrafleXtreme 
MALDI TOF/TOF mass spectrometer (Bruker Daltonics, Germany). Instrument 
calibration was performed using a peptide standard kit (Bruker, Germany) and, before 
sample analysis, laser power was adjusted to provide optimal signal-to-noise ratio. For mass 
fingerprints, brain samples were analyzed with a laser frequency of 1 kHz (3000 laser shots; 
m/z 600-4000). Ion signals mass-identical with products of the POMC-precursor were 
selected and fragmented by tandem mass spectrometry (LIFT technology, with acceleration 
set at 1 kV) using the same samples.  Mass spectra obtained in these experiments were 
processed with the flexAnalysis 3.4 software (Bruker); deduced sequences were 
counterchecked using the ProteinProspector (http://prospector.ucsf.edu). ClinPro Tools 
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software 3.0 (Bruker, Germany) was used for comparison of signal intensities of Pomc-
products; the results are presented as gel view in logarithmic gray scale display mode.  
 
2.5 Mouse Experiments 
2.5.1 Animal care 
All animal procedures were conducted in compliance with protocols approved by local 
government authorities (Bezirksregierung Köln) and were in accordance with National 
Institutes of Health guidelines. All animals were housed in 3-4 animals per cage at 22-24°C 
on a 12 h light/dark cycle with lights on at 6 am. Unless otherwise stated, animals were 
allowed ad libitum access to either normal chow diet (#T.2018.R12, Harlan Teklad Global 
Rodent) containing 53.5 % carbohydrates, 18.5 % protein and 5.5 % fat (12 % fat calories 
from fat) or high-fat diet (#C1057, Altromin) containing 32.7 % carbohydrates, 20% 
protein and 35.5 % fat (55.2 % calories from fat) and drinking water.  
 
2.5.2  Generation of POMCeGFP, POMCΔIR and AgRPtdTomato mice 
Mice expressing the POMCeGFP transgene were generated by crossing C57Bl/6 female to 
transgenic POMCeGFP male mice (Cowley, 2001). To generate POMCΔIR mice, IRfl/fl female 
virgin mice were mated with POMCCrepos/neg, IRfl/fl male mice (Balthasar et al., 2004; 
Bruning et al., 1998; Konner et al., 2007). AgRPCretdTomato mice were generated by crossing 
female ROSA-Red-Tomatofl/fl  (B6;129S6-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J); 
purchased from The Jackson Laboratories, USA) to male AgRPCrepos/neg mice (Tong et al., 
2008). 
 
2.5.3 Analysis of body composition 
Nuclear magnetic resonance was employed to determine whole-body composition of 20 
week-old live animals using the NMR Analyzer minispeq mq7.5 (Bruker Optik, Germany). 
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2.5.4 Serum analyses 
Blood glucose levels were determined from whole venous tail blood using an automatic 
glucose monitor (GlucoMen Glycó, A.Menarini Diagnostics). To obtain serum, blood 
samples were stored on ice, centrifuged at 13.000 rpm at 4°C for 15 mins. Serum samples 
were stored at -20°C until further use and only thawn once for subsequent analyses. Serum 
insulin, leptin, C-peptide and GLP-1 levels were measured by enzyme-linked 
immunosorbent assays according to the manufacturer’s instructions (Mouse/Rat Insulin 
ELISA, Mouse Leptin ELISA, Crystal Chem Inc., USA; Mouse C-peptide (Mouse) ELISA 
Kit, ALPCO, USA; GLP-1 ELISA kit, MyBioSource, USA). Serum non-esterified free fatty 
acids were quantified according to the manufacturer’s instructions (WAKO Chemicals 
GmbH, Germany). 
 
2.5.5 Determination of HOMA-IR 
The HOMA-IR was calculated as follows: fasting serum insulin concentration (µU/ml) 
multiplied by fasting blood glucose levels (mg/dl) divided by 405 (Matthews, 1985). 
 
2.5.6 Analysis of maternal milk composition 
At P19, lactating mothers were separated from their pups for 16 h overnight prior to milk 
collection. Milk was manually collected from deeply anesthetized females for a total of 5 
minutes and stored at -20°C until further use. For determination of milk glucose content, 
milk was diluted 1:2 (v/v) in H2O and measured using the B-Glucose Analyzer (Hemocue, 
Germany). For all subsequent analyses, milk was diluted 1:10 (v/v) in H2O. 2.5 µl of diluted 
milk was used to determine insulin and leptin levels by ELISA assays according to the 
manufacturer’s instruction for serum analyses (Mouse/Rat Insulin ELISA, Mouse Leptin 
ELISA, Crystal Chem, USA). Non-esterified free fatty acids (NEFA) were determined from 
3 µl of the diluted milk according to the manufacturer’s instructions for serum analysis 
(WAKO Chemicals GmbH, Germany). All samples were determined in duplicates. 
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2.5.7 Glucose- and insulin tolerance tests 
Insulin-tolerance tests were performed with 14-week-old animals fed ad libitum. After 
measuring basal blood glucose levels, each animal was intraperitoneally (i.p.) injected with 
0.75 U kg-1 body weight of insulin (Actrapid; Novo Nordisk A/S). Blood glucose levels were 
recorded 15, 30 and 60 minutes after injection. Glucose-tolerance tests were carried out on 
15-week-old mice after a 16 h overnight fast. After determination of fasted blood glucose 
levels, animals were injected i.p. with a bolus of 2 mg mg-1  body weight of glucose (20% 
glucose, Delta Select) and blood glucose levels were monitored 15, 30, 60 and 120 minutes 
after injection.  
 
2.5.8 Determination of glucose-stimulated insulin, C-peptide, GLP-1 and FFA secretion 
After a 16 h overnight fast, approximately 30 µl of blood was collected from all animals. 
Subsequently, all animals were intravenously (i.v.) injected with 1 mg g-1 body weight of 
glucose (20 % glucose, Delta Select, Germany) and blood samples were collected 2, 5, 15 
and 30 mins after injection. For the analysis of glucose-stimulated C-peptide, GLP-1 and 
FFA levels, blood samples were collected only before and 5 mins after i.v. glucose injection. 
Samples used for determination of GLP-1 concentration were immediately treated with a 
soluble dipeptidyl peptidase 4 (DPP4) inhibitor (Merck Millipore, Germany).   
 
2.5.9 Determination of L-arginine-stimulated insulin secretion 
After a 16 h overnight fast, animals were i.p. injected with 3 mg g-1 body weight of L-
arginine dissolved in 0.9 % NaCl solution. Blood samples were collected 0, 2, 5, 15 and 30 
minutes after injection. Insulin was determined from serum using Mouse Insulin ELISA 
(Mouse/Rat Insulin ELISA, Crystal Chem, USA). 
 
2.5.10  Maternal diet manipulation and analytical time-points of their offspring 
3 week-old female C57Bl/6 mice were either fed a NCD or a HFD up to the age of 11 
weeks. At the age of 10 weeks, blood glucose levels were determined and whole venous tail 
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blood was collected, after a 16 h overnight fast, to determine fasted serum insulin. Breedings 
with male C57Bl/6 mice were set up at 11 weeks of age.  NCD-fed females were only used 
for breedings if their HOMA-IR was below or equal to the mean of all NCD-fed females 
and HFD-fed females were only used for breedings if their HOMA-IR was above this 
threshold. During gestation, mice were maintained on the same diet they had received 
before. During lactation, half of the mothers were kept on the same diet they had received 
pregestationally and the other half received the other respective diet. At the day of weaning, 
whole venous tail blood was collected both from the mothers, as well as from their offspring. 
Blood samples were collected from the offspring in the same manner at 8 weeks of age, and, 
after a 16 h fast, at 15 weeks of age before being subjected to a GTT. Body weight of the 
offspring was measured in the second and third week of postnatal life, as well as after week 8 
on a weekly basis. Offspring for phenotypical analyses were sacrificed in a random-fed state 
at 20 weeks of age. IRfl/fl mothers and their offspring were treated the same way except that 
they were only fed a NCD prior to and during gestation.  Every experimental group consists 
of offspring from at least three independent litters. 
 
2.6 Computer analyses 
2.6.1 Software 
All figures and statistical analyses were conducted using Graphpad Prism 5.0. Illustrations 
were drawn in Adobe Illustrator CS4. This thesis was written in Micorosoft® Word 2011 
for Mac. 
 
2.6.2 Statistical analyses 
Data sets with only two independent groups were analyzed for statistical significance using 
unpaired two-tailed Student’s t-test. Data sets with more than two groups were analyzed 
using one-way analysis of variance (ANOVA) followed by Tukey’s posthoc test. For 
statistical analyses of body weight gain, the area-under-the-curve (AUC) from week 2 to 
week 20 was calculated for each mouse and used for further statistical analyses. For statistical 
analyses of GTTs and ITTs, we performed two-way ANOVAs followed by Bonferroni’s 
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posthoc test. Statistically significant outliers were calculated using Grubb’s test for outliers. 
All p-values below 0.05 were considered significant. All displayed values are presented as 
mean + SEM; *p < 0.05. **p < 0.01. ***p < 0.001 versus all other groups within the same 
diet after week 8, unless otherwise indicated. 
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3 Results 
3.1 Establishing a mouse model to define the critical timing of maternal high-fat 
feeding on metabolic programming in the offspring 
 
To determine the most vulnerable time frame of hypothalamic neurocircuit development to 
hormonal insults in response to maternal high-fat diet (HFD)-feeding, we sought to 
establish a model of metabolic programming, which would allow us to independently and 
synergistically manipulate these distinct time-periods and analyze their respective effects on 
the metabolic phenotype in the offspring.   
Female C57Bl/6 virgin mice were either fed a normal chow diet (NCD) or a HFD for 
8 weeks prior to gestation. During gestation, the mice were maintained on the same diet that 
they received during the pre-gestational period. Importantly, at the day of birth (DOB), 
litter size was adapted to 6-7 pups per mother to assure the same quantitative nutritional 
availability for each litter, since it had previously been demonstrated that litter size reduction 
increases the propensity to develop metabolic diseases in the offspring during adulthood 
(Habbout et al., 2013). Additionally, at DOB, half of the NCD-fed mothers were exposed 
to a HFD (i.e. NCD/NCD and NCD/HFD), and vice versa, half of the mothers fed a HFD 
pre-gestationally and during gestation were exposed to a NCD during the period of lactation 
(i.e. HFD/NCD and HFD/HFD). After weaning, all offspring were fed a NCD until the 
age of 8 weeks, after which each group of offspring was again divided into a group that was 
exposed to either a NCD or a HFD for the following 12 weeks up to the age of 20 weeks. 
This strategy allowed us to directly assess whether an altered maternal diet modulates the 
propensity of the offspring to respond to exposure to HFD later in life. This experimental 
outline resulted in a total of 8 different groups of offspring that differed in the prenatal 
maternal diet, the postnatal maternal diet and in the diet of the offspring after 8 weeks of age 
(Figure 3.1.1). 
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Figure 3.1.1: Experimental outline to determine the critical timing of maternal 
HFD-feeding on metabolic programming in the offspring   
Female C57Bl/6 virgin mice were fed with either a normal chow diet (NCD) or a high-fat diet 
(HFD) from 4 to 11 weeks of age. During gestation, mice were maintained on the same diet that 
they had received before. On the day of birth (DOB) of the offspring, litter size was reduced to 6-7 
animals per mother and half of the NCD-fed mothers were exposed to a HFD, while half of the 
HFD-fed mothers were exposed to a NCD during lactation. After weaning, all offspring was exposed 
to a NCD until 8 weeks of age, after which each group of offspring was divided into groups receiving 
either a NCD or a HFD until 20 weeks of age. Light blue lines indicate NCD-feeding and dark blue 
lines indicate HFD-feeding.   
 
 
 
Pregestational HFD-feeding for the period of 7 weeks resulted in a moderate, but 
significantly increased body weight (Figure 3.1.2 A), as well as elevated fasting blood glucose 
concentrations (Figure 3.1.2 B) and an approximately 7-fold-increase in the homeostatic 
model assessment indices of insulin resistance (HOMA-IR) (Figure 3.1.2 C) in HFD-fed 
females at 10 weeks of age, indicating that pre-gestational HFD-feeding causes insulin 
resistance. Interestingly, HFD-exposure during lactation, independent of the prenatal 
maternal diet, resulted in a slight elevation of serum insulin concentrations in the mothers 
(Figure 3.1.2 D), but most importantly, in a significant increase in serum insulin levels in 
the offspring at 3 weeks of age (Figure 3.1.2 E). Together, these data demonstrate that 
maternal diet changes after parturition affect the metabolic phenotype of the mother, which 
results in significant changes in the offspring’s insulin levels. Thus, altering maternal diet 
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during gestation and lactation is a valid model to study the independent and synergistic 
effects of maternal HFD-feeding during distinct periods of hypothalamic neurocircuit 
formation on the metabolic phenotype in the offspring.  
 
 
 
Figure 3.1.2 Maternal HFD-feeding induces pregestational metabolic 
abnormalities and hyperinsulinemia during lactation in the offspring 
Maternal pregestational (A) body weight, (B) fasted blood glucose levels and (C) homeostatic model 
assessment indices of insulin resistance (HOMA-IR) at 10 weeks of age. Preweaning (A) maternal 
serum insulin levels in the fed state at the age of 17 weeks. (E) Preweaning serum insulin levels in the 
offspring in the fed state. NCD, normal chow diet; HFD, high fat diet. Data are presented as mean 
+/- SEM, **p<0.01, ***p<0.001 versus all other groups.  
 
 
 
3.2 Maternal HFD-feeding exclusively during lactation predisposes the offspring 
for metabolic disorders 
 
We first subjected all groups of offspring to a thorough metabolic characterization. When 
male offspring were fed a NCD, only mice whose mothers were fed a HFD exclusively 
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during lactation (NCD/HFD) displayed significantly increased body weight throughout 
their adult life compared to all other groups (Figure 3.2.1 A).  Consistently, NCD/HFD 
mice showed elevated body fat content (Figure 3.2.1 B), as well as significantly increased 
perigonadal fat pad weight at 20 weeks of age (Figure 3.2.1 C) compared to NCD/NCD 
mice on a NCD. This increase in adiposity in NCD/HFD mice exposed to NCD 
throughout adulthood was further accompanied by significantly elevated serum leptin levels 
at 15 weeks of age (Figure 3.2.1 D). Moreover, NCD/HFD mice showed enhanced 
susceptibility to develop insulin resistance (Figure 3.2.1 E) and glucose intolerance (Figure 
3.2.1 F) when compared to any other group of offspring. In contrast, male offspring 
consistently exposed to maternal HFD-feeding (HFD/HFD) only showed elevated body fat 
content when exposed to a HFD after 8 weeks of age, which however did not exceed the 
adiposity seen in NCD/HFD mice on a HFD (Figure 3.2.1 B). Surprisingly, male 
HFD/NCD offspring displayed significantly decreased body weight on a HFD throughout 
lifetime, suggesting a partial resistance against diet-induced obesity (Figure 3.3.1 A).  
Notably, although most metabolic abnormalities were only seen in male NCD/HFD 
mice when exposed to a NCD, female offspring from NCD/HFD mothers displayed a 
similar obese phenotype, only when challenged with a HFD after 8 weeks of age (Figure 
3.2.2).  NCD/HFD female offspring on a HFD displayed significantly increased body 
weight gain (Figure 3.2.2 A), which was due to increased overall body fat content (Figure 
3.2.2.B) that was also reflected in elevated perigonadal fat pad weight (Figure 3.2.2 C), as 
well as in their serum leptin levels (Figure 3.2.2 D). Moreover, NCD/HFD females showed 
a tendency towards impaired insulin sensitivity (Figure 3.2.2 E) and significantly impaired 
glucose tolerance (Figure 3.2.2 F).  
Taken together, our model of metabolic programming consistently demonstrates 
that exposure to a HFD exclusively during the lactation phase in mice exerts the strongest 
effects on alterations in energy and glucose homeostasis in both male and female offspring.  
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Figure 3.2.1 Maternal HFD-feeding exclusively during lactation predisposes the 
offspring for metabolic disorders   
The following metabolic parameters were analyzed in all eight groups of male offspring. (A) Body 
weight on (i) normal chow diet (NCD) or (ii) high fat diet (HFD), (B) body fat content and (C) 
perigonadal fat pad weight at 20 weeks, (D) fasted serum leptin levels and (E) homeostatic model 
assessment indices of insulin resistance (HOMA-IR) at 15 weeks and (F) glucose tolerance tests (GTT) 
at 15 weeks of age on i) NCD and ii) HFD. Data are presented as mean +/- SEM, *p<0.05, **p<0.01, 
***p<0.001 versus all other groups within the same diet after the age of 8 weeks, if not indicated 
otherwise. 
 
   3 Results 
 52 
 
Figure 3.2.2 Maternal HFD-feeding exclusively during lactation predisposes the 
offspring for metabolic disorders - also in females   
The following metabolic parameters were analyzed in all eight groups of female offspring. (A) Body 
weight on (i) normal chow diet (NCD) or (ii) high fat diet (HFD), (B) body fat content and (C) 
perigonadal fat pad weight at 20 weeks, (D) fasted serum leptin levels and (E) homeostatic model 
assessment indices of insulin resistance (HOMA-IR) at 15 weeks and (F) glucose tolerance tests (GTT) 
at 15 weeks of age on i) NCD and ii) HFD. Data are presented as mean +/- SEM, *p<0.05, **p<0.01, 
***p<0.001 versus all other groups within the same diet after the age of 8 weeks, if not indicated 
otherwise. 
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3.3 Effects of maternal HFD-feeding during lactation on hypothalamic 
neurocircuits  
 
Upon identifying the lactation phase as the most critical period where altered maternal diet 
impairs metabolic homeostasis in the offspring, we focused on comparing NCD/NCD and 
NCD/HFD male offspring to define the molecular mechanism(s) underlying the obese and 
glucose intolerant phenotype of NCD/HFD mice. First, we determined mRNA expression 
of hypothalamic neuropeptides critically involved in the regulation of energy and glucose 
homeostasis. Surprisingly, although there was no difference in expression of any ARH 
neuropeptide genes, i.e. Pomc, Agrp and Npy (Figure 3.3.1 A) between NCD/NCD and 
NCD/HFD-mice, mRNA expression of one of their anorexigenic downstream targets 
thyrotropin-releasing hormone (Trh), which is predominantly but not exclusively expressed 
in the PVH (Segerson, 1987), was significantly lower in NCD/HFD offspring both at 3 and 
20 weeks of age (Figure 3.3.1 B). These experiments indicate that in the absence of 
alterations of Pomc and Agrp/Npy-expression in the ARH, expression of one of the 
melanocortin-effector pathways in the PVH is impaired.  
 
 
 
Figure 3.3.1 Hypothalamic neuropeptide expression profile reveals alterations 
only in ARH downstream neurons  
Quantitative real-time PCR analysis of hypothalamic (A) pro-opiomelanocortin (Pomc), agouti-related 
peptide (Agrp) and neuropeptide Y (NPY) and (B) thyrotropin-releasing hormone (Trh) mRNA 
expression in NCD/NCD and NCD/HFD offspring at 3 and 20 weeks of age. NCD, normal chow 
diet; HFD, high fat diet; Data are presented as mean +/- SEM, *p<0.05.  
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Thus, we further investigated mechanisms, which could result in an impairment of 
POMC- and/or AgRP-neuron function as a consequence of maternal HFD-feeding during 
lactation. To determine whether hypothalamic inflammation in response to postnatal 
maternal HFD-feeding contributed to the impairment of the melanocortin circuitry, we 
analyzed mRNA expression of classical inflammatory markers, such as Tnf, Il6 and Il1b, in 
the hypothalamus. However, we could not detect differences in the hypothalamic expression 
of any of these genes between NCD/NCD and NCD/HFD offspring at 3 and 20 weeks of 
age (Figure 3.3.2). 
 
 
Figure 3.3.2 Maternal HFD-feeding during lactation does not induce 
hypothalamic inflammation in the offspring  
Quantitative real-time PCR analysis of hypothalamic tumor necrosis factor (Tnf), interleukin 6 
(Il6) and interleukin 1 beta (Il1b) mRNA expression of NCD/NCD and NCD/HFD 
offspring at 3 and 20 weeks of age on a NCD. NCD, normal chow diet; HFD, high fat diet. 
Data are presented as mean +/- SEM.  
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Next, we analyzed the effect of postnatal maternal HFD-feeding on the cell number 
of ARH neurons by employing our postnatal feeding paradigm to female C57Bl/6 mice that 
were crossed to male transgenic mice expressing the enhanced green fluorescent protein 
(eGFP) under the transcriptional control of the POMC promoter (POMCeGFP) (Cowley et 
al., 2001); and further to females homozygously carrying a floxed Rosa26-tdTomato allele 
encoding red fluorescent protein (Jackson Laboratories, Bar Har, ME, USA) that were 
crossed to male mice expressing Cre recombinase under the transcriptional control of the 
AgRP promoter (Tong et al., 2008) to generate AgRPtdTomato mice. Consistent with unaltered 
Pomc- and Agrp/Npy expression, there was no difference in the number of eGFP-positive 
POMC, or tdTomato-positive AgRP neurons between NCD/NCD and NCD/HFD 
offspring (Figure 3.3.3). Thus, maternal high fat feeding appears neither to affect 
neurogenesis/survival of ARH neurons, nor mRNA-expression of key neuropeptides in the 
ARH, which control energy homeostasis.  
 
  
Figure 3.3.3 Maternal HFD-feeding during lactation does not affect ARH 
neuronal cell number  
Analysis of POMC (left) and AgRP (right) neurons in the arcuate nucleus of the hypothalamus 
(ARH) in POMCeGFP and AgRPtdTomato mice, respectively, at 8 weeks of age (scale bar = 100 µm). 
NCD, normal chow diet; HFD, high fat diet. 
 
 
Of note, AgRP can be modulated by, but does not depend on posttranslational 
modifications to decrease TRH expression in the PVH (Creemers et al., 2006; Fekete et al., 
2001). However, POMC has to undergo proprotein-convertase (PC)-1, -2 and 
carboxypeptidase (CPE)-mediated processing to generate the active neuropeptide alpha-
melanocyte-stimulating-hormone (α-MSH), which exerts its anorexigenic functions, in part 
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via upregulation of TRH (Fekete et al., 2000; Pritchard and White, 2007). Thus, we 
investigated whether POMC processing might be impaired in NCD/HFD offspring.  
Hypothalamic mRNA expression of Pcsk1, Pcsk 2 (respectively PC-1 and PC-2) and Cpe did 
not show any differences between groups of offspring (Figure 3.3.4 A). Moreover, MALDI-
TOF mass spectrometry of dissected ARH samples showed nearly identical peptide signals, 
including ions that are mass-identical with products of the POMC precursor protein (i.e. α-
MSH, di-acetylated α-MSH and joining peptide) (Pritchard and White, 2007) between 
NCD/NCD and NCD/HFD offspring (Figure 3.3.4 B). Together, these experiments 
exclude an impairment of POMC processing to α-MSH as the underlying cause for the 
obese phenotype in NCD/HFD offspring.  
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Figure 3.3.4 POMC processing to α-MSH is not impaired in response to postnatal 
HFD-exposure  
(A) Quantitative real-time PCR analysis of hypothalamic proprotein convertase subtilisin/kexin type 1 
(Pcsk1), proprotein convertase subtilisin/kexin type 2 (Pcsk2) and carboxypeptidase E (Cpe) mRNA 
expression at 3 and 20 weeks of age on NCD. (B) MALDI-TOF mass spectra obtained by profiling 
extracts of the arcuate nucleus of the hypothalamus (ARH) at 20 weeks of age. Prominent ion signals 
are labeled. i) Comparison of mass fingerprints of products of the POMC precursor (α-MSH, Di-Ac-
MSH, joining peptide (JP)). The ion-signal at 1622.81 (asterisk) is composed of two substances 
(including α-MSH). The arrow marks processed and biologically more potent di-acetylated α-MSH. 
b) Isotopic pattern and signal intensity of di-acetylated α-MSH before (lower traces) and after Stage 
Tip concentration. ii) MALDI-TOF/TOF fragment spectrum of di-acetylated α-MSH purified and 
concentrated with Stage Tips. Y- and b-type fragment ions are labeled, which confirmed the amino 
acid sequence of di-acetylated α-MSH. iii) Gel view of mass spectra from preparation of ARH and 
pituitary gland (Pit) demonstrating identical processing of Pomc-products in all samples. NCD, 
normal chow diet; HFD, high fat diet. Data are presented as mean +/- SEM.  
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Next, we analyzed whether maternal HFD-feeding during lactation had an effect on the 
electrophysiological properties of POMC neurons in the offspring. Whole-cell and 
perforated patch clamp recordings on POMCeGFP transgenic NCD/NCD and NCD/HFD 
offspring indicated that maternal HFD-feeding during lactation did not result in any 
differences in spontaneous firing frequency of POMC-neurons (Figure 3.3.5 A), POMC-
neuron resting membrane potential (Figure 3.3.5 B), or in the relative synaptic input onto 
POMC neurons (Figure 3.3.5 C).  
 
 
Figure 3.3.5 POMC electrophysiological properties are unaltered in offspring 
from postnatally HFD-fed mothers  
(A) Spontaneous spike frequency and (B) membrane potential of POMCeGFP neurons obtained by 
perforated patch clamp recordings (n=13 neurons obtained from n=3 mice). (C) Whole-cell 
recordings showing the relative synaptic input on POMCeGFP neurons (n=13vs14 neurons obtained 
from n=5vs8 mice). NCD, normal chow diet; HFD, high fat diet. Data are presented as mean +/- 
SEM.  
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Collectively, these data demonstrate that maternal HFD-feeding exclusively during 
lactation permanently decreases anorexigenic TRH expression in the PVH, which is a target 
of POMC- and AgRP-neurons in the ARH, without altering ARH neuropeptide gene 
expression, POMC neuronal cell number, neuropeptide processing of POMC to di-
acetylated α-MSH and/or electrophysiological properties of POMC neurons.  
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3.4 Maternal HFD-feeding exclusively during lactation impairs axonal 
projections of ARH neurons to intra-hypothalamic target sites 
 
Considering that altering maternal diet selectively during lactation, the phase of 
hypothalamic neurocircuit development in which axonal projections are formed in rodents, 
had the strongest impact on the metabolic fate of the offspring, we next analyzed the 
immunoreactivity of α-MSH- and AgRP-containing fibers in three of the main ARH 
downstream hypothalamic projection areas: the PVH, DMH and LH. Of note, the PVH 
consists of distinct functional subcompartments that regulate neuroendocrine, behavioral 
and autonomic responses to control energy and glucose homeostasis (Biag et al., 2012). 
Neuroendocrine neurons, such as TRH neurons, reside mainly in the anterior two thirds of 
the PVH (referred to as PVHant), whereas preautonomic neurons are predominantly found in 
the posterior part of the PVH (referred to as PVHpost) (Biag et al., 2012). Due to this distinct 
compartmentalization and the associated diverse functions of the PVH, we differentiated 
both, the PVHant and the PVHpost, in our analysis. Quantification of the fiber density in the 
PVHant (Figure 3.4.1 A), the PVHpost (Figure 3.4.1 B), the DMH (Figure 3.4.1 C) and the 
LH (Figure 3.4.1 D) revealed robust reductions in both, the α-MSH and AgRP fiber 
densities in NCD/HFD offspring compared to NCD/NCD offspring.  
Thus, maternal HFD-feeding results in a consistent decrease of ARH neuronal fiber 
densities in hypothalamic areas critically involved in the neuroendocrine and autonomic 
regulation of energy homeostasis, likely due to impaired axon formation in the offspring. 
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Figure 3.4.1 Maternal HFD-feeding exclusively during lactation impairs axonal 
projections of ARH neurons to intra-hypothalamic target sites  
Images and quantification of α-melanocyte-stimulating hormone (α-MSH) and agouti-related 
peptide (AgRP) immunoreactive fibers innervating (A) the anterior endocrine paraventricular nucleus 
of the hypothalamus (PVHant), (B) the posterior preautonomic PVHpost, (C) the dorsomedial nucleus 
of the hypothalamus (DMH) and (D) the lateral hypothalamic area (LH) at 8 weeks of age. White 
boxes indicate area of quantification. 3V, third ventricle; fx, fornix; Scale bar = 100 µm. NCD, 
normal chow diet; HFD, high fat diet. Data are presented as mean +/- SEM, *p<0.05, **p<0.01. 
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3.5 Deciphering the role of neuronal insulin signaling in the predisposition for 
metabolic disorders in NCD/HFD offspring 
 
Although maternal HFD-feeding during lactation did not affect body weight (Figure 3.5.1 
A), it significantly increased the glucose, insulin, leptin and non-esterified fatty acid content 
of the milk in NCD/HFD mothers (Figure 3.5.1 B-E), which was associated with distinct 
hyperinsulinemia in the NCD/HFD offspring at 3 weeks of age (Figure 3.1.2 E). Moreover, 
given the well-defined axonotrophic role of leptin on ARH neurons during development 
(Bouret, 2004, Bouyer 2013), we sought to identify the potential contribution of neuronal 
insulin signaling during the early postnatal phase in impairing melanocortin projections in 
response to maternal HFD-feeding.  
 
 
 
Figure 3.5.1 Milk composition is highly enriched in mothers exposed to HFD 
during lactation  
(A) Maternal body weight changes between postnatal day 4 (P4) and P19, (B) glucose, (C) insulin 
and (D) leptin levels, as well as (E) non-esterified free fatty acid (FFA) content in the milk at P19 in 
mothers consistently exposed to a NCD during gestation and lactation (NCD/NCD) and mothers 
fed a HFD only during lactation (NCD/HFD). NCD, normal chow diet; HFD, high fat diet. Data 
are presented as mean +/- SEM, p*<0.05, **p>0.01  
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To this end, we specifically inactivated the insulin receptor (IR) from POMC 
neurons in NCD/NCD and NCD/HFD offspring by crossing female IR floxed/floxed 
(IRfl/fl) mice with male IRfl/fl mice expressing Cre recombinase under the control of the 
POMC promoter (Balthasar et al., 2004; Bruning et al., 1998; Konner et al., 2007) and 
further subjected the mothers to our postnatal feeding paradigm. All groups of offspring 
were challenged with a HFD after 8 weeks of age, resulting in 4 groups of offspring differing 
in both, the maternal diet during lactation and in the presence (NCD/NCD ctrl and 
NCD/HFD ctrl) and absence (NCD/NCD POMCΔIR and NCD/HFD POMCΔIR) of IR-
expression on POMC neurons.  
Similar to our previous results, maternal HFD-feeding exclusively during lactation 
did not alter body weight between NCD/NCD ctrl and NCD/HFD ctrl offspring on HFD, 
and also had no effect on the respective POMC-specific IR-deficient offspring (Figure 3.5.2 
A). Despite showing no increases in body weight, NCD/HFD offspring developed greater 
adiposity independent of their genotype, as revealed by elevated body fat content (Figure 
3.5.2 B), increased perigonadal fat pad weight (Figure 3.5.2 C) and elevated serum leptin 
levels (Figure 3.5.2 D). Similarly, both measures of insulin sensitivity, i.e. the HOMA-IR 
(Figure 3.5.2 E) and insulin tolerance tests (ITT) (Figure 3.5.2 F) showed tendencies 
towards an impaired insulin sensitivity in both NCD/HFD ctrl and in NCD/HFD 
POMCΔIR offspring. Thus, POMC-specific inactivation of IR-signaling did not affect 
adiposity, nor the impaired insulin sensitivity in offspring from mothers fed a HFD 
exclusively during lactation.  
However, when subjected to a glucose tolerance test (GTT), NCD/HFD ctrl mice displayed 
a pronounced glucose intolerance, which was rescued to NCD/NCD levels in NCD/HFD 
POMCΔIR offspring (Figure 3.5.2 G). Together, these results point to a distinct role for 
abnormal neuronal insulin signaling in response to maternal postnatal HFD-feeding in 
predisposing the offspring for an impaired glucose tolerance throughout lifetime.   
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Figure 3.5.2 POMC-specific IR-deficiency does not protect from adiposity or 
insulin resistance, but improves glucose tolerance in NCD/HFD offspring 
(A) Body weight, (B) body fat content and (C) perigonadal fat pad weight at 20 weeks of age. (D) 
Fasted serum leptin levels and (E) homeostatic model assessment indices of insulin resistance 
(HOMA-IR) at 15 weeks of age, (F) insulin tolerance tests (ITT) and (G) glucose tolerance tests 
(GTT) at 15 weeks of age. NCD, normal chow diet; HFD, high fat diet. Data are presented as mean 
+/- SEM, *p<0.05, **p<0.01, ***p<0.001 versus all other groups of offspring, unless otherwise 
indicated.  
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3.6 POMC-specific IR-deficiency in NCD/HFD offspring prevents altered 
axonal projections of POMC neurons to preautonomic PVH  
  
To decipher persistent hypothalamic cellular changes responsible for the metabolic rescue of 
glucose tolerance in NCD/HFD POMCΔIR mice, we analyzed fiber densities of ARH 
neurons to the distinct subcompartments of the PVH at 8 and 20 weeks of age, as well as to 
the DMH and LH at 20 weeks of age. Loss of the IR specifically on POMC neurons did not 
change α-MSH or AgRP fiber densities to any hypothalamic target site in NCD/NCD 
offspring at any age (Figure 3.6.1). Moreover, maternal HFD-feeding exclusively during 
lactation resulted in a decrease of α-MSH fiber density in the neuroendocrine PVHant in 
young and old NCD/HFD animals (Figure 3.6.1 A), as well as in the DMH (Figure 3.6.1 
C) and LH (Figure 3.6.1 D), independent of their genotype. However, although 
NCD/HFD POMCΔIR mice displayed a similar decrease in α-MSH fiber density in the 
neuroendocrine PVHant region as their control littermates (Figure 3.6.1 A), specific 
inactivation of the IR on POMC neurons protected against a decrease in the α-MSH fiber 
density in the preautonomic PVHpost compartment resulting in a persistent restoration of α-
MSH fiber density in NCD/HFD POMCΔIR offspring close to NCD/NCD levels both at 8 
and 20 weeks of age (Figure 3.6.1 B).  
In contrast, AgRP fiber densities were significantly reduced in NCD/HFD offspring 
independent of their genotype in the PVHant, DMH, LH and most importantly, also the 
PVHpost at the age of 20 weeks (Figure 3.6.1). Collectively, our results suggest that 
hyperinsulinemia in response to maternal HFD-feeding during lactation impairs axonal 
outgrowth of POMC neurons specifically to the preautonomic compartment of the PVH.  
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Figure 3.6.1 POMC-specific IR-deficiency in NCD/HFD offspring rescues POMC 
axonal projections to preautonomic regions in the PVH  
Images and quantification of α-melanocyte-stimulating hormone (α-MSH) and agouti-related 
peptide (AgRP) immunoreactive fibers innervating (A) the anterior neuroendocrine paraventricular 
nucleus of the hypothalamus (PVHant) and (B) the posterior preautonomic PVHpost at 8 and 20 weeks 
age, as well as (C) the dorsomedial nucleus of the hypothalamus (DMH) and (D) lateral 
hypothalamic area (LH) at 20 weeks of age. White boxes indicate area of quantification. NCD, 
normal chow diet; HFD, high fat diet; IR, insulin receptor; 3V, third ventricle; fx, fornix; Scale bar = 
100 µl. Data are presented as mean +/- SEM, *p<0.05, **p<0.01 versus all other groups of offspring, 
unless otherwise indicated.  
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3.7 Effects of maternal HFD-feeding during lactation and POMC-specific IR-
deficiency on pancreatic β-cells 
 
Reciprocal neural connections between the hypothalamus and preganglionic motor neurons 
of the autonomic nervous system play an important role in the regulation of energy and 
glucose homeostasis (Marino et al., 2011). Therefore, we aimed to identify changes in the 
autonomic tone in peripheral organs that could possibly be linked to the specific restoration 
of α-MSH axonal projections to the preautonomic compartment of the PVHpost in 
NCD/HFD POMCΔIR mice.  Given the distinct rescue of glucose tolerance in POMC-
specific IR-deficient NCD/HFD offspring in the absence of alterations in insulin sensitivity, 
we analyzed the parasympathetic innervation of pancreatic β-cells by staining for vesicular 
acetylcholine transporter (vAChT) (Rossi et al., 2005). Strikingly, the number of vAChT-
immunoreactive buttons per islet area was significantly reduced in NCD/HFD ctrl offspring, 
but rescued to NCD/NCD levels in NCD/HFD POMCΔIR mice (Figure 3.7.1).  
In line with the decreased parasympathetic innervation of pancreatic β-cells in 
NCD/HFD ctrl mice, glucose-stimulated insulin secretion was significantly decreased 
compared to NCD/HFD POMCΔIR offspring (Figure 3.7.2 A). Consistently, C-peptide 
levels were decreased 5 minutes after intravenous glucose injection in NCD/HFD ctrl 
offspring (Figure 3.7.2 C). In contrast, this defect in insulin secretion in NCD/HFD ctrl 
mice was not seen upon L-arginine stimulation (Figure 3.7.2 B) and was not associated with 
glucose-stimulated alterations in levels of free fatty acids (FFA) or glucagon-like peptide 1 
(GLP-1) (Figure 3.7.2 D). Moreover, neither maternal HFD-feeding during lactation, nor 
POMC-specific IR-deficiency had any effect on the average pancreatic β-cell-mass or the 
average islet size of the pancreas (Figure 3.7.2 E). Taken together, our results indicate that 
POMC-specific IR-deficiency improves glucose-stimulated insulin secretion presumably in 
part via modulation of the parasympathetic tone in offspring from postnatally HFD-fed 
mothers.  
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Figure 3.7.1 Increased parasympathetic innervation of pancreatic β -cells upon 
POMC-specific IR-deficiency in NCD/HFD offspring 
Images and quantification of the parasympathetic marker vesicular acetylcholine transporter (vAChT, 
green) on pancreatic β-cells (insulin, red) at 20 weeks of age. NCD, normal chow diet; HFD, high 
fat diet. Scale bar = 50 µm. Data are presented as mean +/- SEM, *p < 0.05 versus all other groups of 
offspring.  
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Figure 3.7.2 POMC-specific IR-deficiency protects from impaired glucose-
stimulated insulin secretion in offspring from postnatally HFD-fed mothers  
(A) Glucose-stimulated insulin secretion, (B) L-arginine-stimulated insulin secretion, (C) C-peptide, 
(D) Glucagon-like peptide 1 and (E) non-esterified fatty acid (FFA) concentrations 0 and 5 minutes 
after intravenous glucose injection at 15 weeks of age. (E) Images and quantification of total β-cell 
mass and average β-cell islet size at 20 weeks of age. NCD, normal chow diet; HFD, high fat diet. 
Scale bar = 300 µm, *p<0.05, **p<0.01 versus all other groups of offspring, unless otherwise 
indicated. 
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4 Discussion 
 
4.1 Altering maternal diet during hypothalamic neurocircuit development as a 
valuable model to study metabolic programming 
 
The findings that have led to the concept of metabolic programming convincingly presented 
an additional contributor to the obesity and T2DM epidemic that we are facing today. The 
fact that maternal health and even nutrition strongly impact on the development of key 
organs, such as the brain, thereby predisposing the unborn child to metabolic disorders 
throughout lifetime has received considerable amount of attention over the last decades. 
However, despite the multitude of studies already carried out in this field of research, to date 
we still know very little about the cellular and molecular alterations that are responsible for 
an increased propensity towards an impaired regulation of energy homeostasis. This lack of 
knowledge mainly results from the huge variation of animal models used to study these 
effects, which differed not only in the use of species, but also in the duration and magnitude 
of environmental insults to the offspring, giving rise to inconsistent and even conflicting 
results. These variations made it difficult to dissociate between morphological alterations 
that are actually causal and not just coincidental to the obese phenotype seen in offspring of 
obese and/or diabetic mothers. Given the fact that in contrast to humans, the main two 
phases of hypothalamic neurocircuit development are separated into a prenatal and postnatal 
period in rodents, we used this discrepancy between these species to our advantage. We 
established a mouse model of metabolic programming in which we did not only assess the 
effect of consistent, but also alternating maternal HFD-feeding between gestation and 
lactation on the offspring’s health, which allowed us to identify the most sensitive phase of 
hypothalamic neurocircuit development to the hormonal changes in response to maternal 
HFD-exposure. Moreover, the utilization of mice instead of rats further enabled us to make 
use of genetic tools to clearly decipher the role of abnormal insulin signaling in metabolic 
programming.  
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4.1.1 Environmental insults during the postnatal phase of development result in the 
strongest metabolic impairments in the offspring in rodents 
 
Using our model of metabolic programming, we could show that maternal metabolic 
changes in response to acute HFD-feeding starting during lactation is sufficient to induce 
metabolic disorders, both in male and female offspring. To our knowledge, so far only one 
study has manipulated the maternal diet both independently and synergistically during these 
distinct phases of hypothalamic neurocircuit development in a similar manner (Sun et al., 
2012). Despite clear differences in study design: 1) rats versus mice, 2) maternal HFD-
feeding not pregestationally, but only starting during gestation or lactation and 3) cross 
fostering instead of postnatal diet switch, Sun et al. also identified the lactation phase as the 
most sensitive period to hormonal insults in response to maternal HFD-feeding. However, 
in contrast to our study, in which we do not see gross metabolic impairments of offspring 
from consistently HFD-fed mothers, Sun et al. report that offspring from mothers fed HFD 
both pre- and postnatally share the same metabolic impairments with offspring cross-
fostered to HFD-fed mothers. Of note, due to their cross-fostering paradigm, in their model 
of metabolic programming, maternal metabolic homeostasis, as well as milk composition do 
not differ between these two groups of offspring. Thus, considering the results obtained 
from our study, i.e. that hormonal alterations during the postnatal phase are critical in the 
predisposition for metabolic disorders, it is not surprising that these two groups share the 
same phenotype, especially since these mothers had not developed obesity or insulin 
resistance prior to or during gestation (Sun et al., 2012). Moreover, other models of 
postnatal overnutrition, such as litter size adaptation and cross-fostering experiments further 
support our findings by demonstrating that an altered metabolic milieu during early 
postnatal development in rodents is not only sufficient to predispose for metabolic disorder, 
but can even partially override prenatal factors and genetic predisposition to develop obesity 
(Glavas et al., 2010; Gorski et al., 2006).  
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4.1.2 Impairment of ARH neuronal axon formation might be the common and main 
driver of metabolic programming 
 
In the search of hypothalamic cellular changes underlying the obese and glucose intolerant 
phenotype in the offspring, we investigated developmental processes that occur postnatally 
and could possibly be affected in response to maternal HFD-feeding during lactation. 
Postnatal maternal HFD-feeding neither induced neuronal cell death of ARH neurons nor 
affected synaptogenesis (at least not onto POMC neurons). Moreover, our results repeatedly 
showed no changes in ARH neuropeptide gene expression, POMC processing to α-MSH or 
hypothalamic inflammation. In contrast, fiber densities of POMC and AgRP/NPY neurons 
were severely reduced in all major intrahypothalamic target sites, i.e. PVH, DMH and LH 
in offspring from postnatally HFD-fed mothers, suggesting an impairment of ARH neuronal 
axon formation. Interestingly, a variety of models such as postnatal overnutrition due to 
litter size reduction, streptozotocin-induced maternal hyperglycemia during gestation and 
lactation, maternal obesity in response to consistent maternal HFD-feeding, as well as 
neonatal nutritional deprivation have demonstrated decreased POMC and/or AgRP/NPY 
innervation of the PVH in the offspring (Bouret, 2012; Coupe et al., 2010; Delahaye et al., 
2008; Kirk et al., 2009; Steculorum and Bouret, 2011). Moreover, rats genetically 
predisposed for diet-induced obesity (DIO) and obese leptin-deficient mice also display 
decreased PVH innervation of POMC and AgRP/NPY neurons (Bouret et al., 2004b; 
Bouret et al., 2008). Thus, these consistent findings of impaired ARH neuronal axon 
formation across studies suggest that this defect may be a common driver for metabolic 
programming and thus critical for the impaired regulation of energy and glucose homeostasis 
in offspring from obese, diabetic and even malnourished mothers. Nevertheless, we cannot 
exclude that impairment of other neurodevelopmental processes specifying neuronal cell 
number or affecting neuropeptide expression – as described in other models of metabolic 
programming – adds to the dysregulated metabolism in offspring of obese or diabetic 
mothers (for review, see (Plagemann, 2012)). However, most studies describing alterations 
in the number of anorexigenic or orexigenic neurons, as well as malformations of 
hypothalamic nuclei, did not assess the effects on ARH projection formation in the same 
model (Chang et al., 2008; Chen et al., 2008; Gout et al., 2010; Plagemann et al., 1999a; 
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Plagemann et al., 1999b). This lack of information clearly exacerbates the possibility to draw 
any conclusions about the role of the observed modifications in metabolic programming. 
Our results however, as well as the severe inconsistencies concerning the effects on prenatal 
developmental processes between other studies therefore question the overall contribution of 
alterations in neuronal cell number or neuropeptide expression and suggest that in contrast 
to impaired ARH axon formation, they play a minor or additive role in the predisposition 
for metabolic disorders.  
Of note, so far, the effects of an abnormal developmental environment have mainly 
been studied on ARH neuronal innervation of intra-hypothalamic target sites of POMC and 
AgRP/NPY neurons. However, these neurons project to various other sites throughout the 
CNS implicated in the regulation of energy balance, for example via modulation of the 
autonomic nervous or mesolimbic reward system. One of the main contributors of the 
worldwide obesity epidemic is considered to be the ready-availability of palatable, high-fat 
food in westernized societies (WHO, 2013c). Given that the desire to eat is not only driven 
by the current energy or nutritional status, but also by the rewarding or hedonistic aspect of 
food, alterations in the efficacy and sensitivity of the central mesolimbic reward pathway 
have been associated with the development and manifestation of obesity (for review, see 
(Palmiter, 2007)). Along these lines, several studies have demonstrated that the perinatal 
nutritional environment has long-lasting effects on these neurocircuits leading to an 
impaired regulation of this reward-based feeding behavior and thereby predisposes for 
metabolic disorders throughout lifetime. Offspring from mothers exposed to a “junk food” 
or “cafeteria” diet (i.e. a dietary mixture of a high fat and high sugar diet with a normal 
chow diet) during gestation and lactation display an accelerated preference for fatty, sugary 
and salty food along with an increased frequency of feeding episodes throughout lifetime 
(Bayol et al., 2007; Ong and Muhlhausler, 2011; Wright et al., 2011b). Moreover, maternal 
perinatal HFD-feeding leads to an altered responsiveness of dopaminergic neurons (Naef et 
al., 2008). On a molecular level, these behavioral changes are associated with elevated levels 
of tyrosine hydroxylase and dopamine in distinct regions of the mesolimbic system, 
including in the VTA and nucleus accumbens (NAc) (Naef et al., 2008). Although it has not 
been investigated whether impaired maternal nutrition affects neuronal axon formation in 
the mesolimbic system directly, development of projections from the VTA to the NAc 
continues during the postnatal life in rodents and therefore represents a likely target for 
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developmental environmental insults (Antonopoulos et al., 2002; Kalsbeek et al., 1988). In 
addition to impaired regulation of hedonic feeding, altered maternal metabolic homeostasis 
has been associated with the development of mental health and behavioral disorders 
including anxiety, depression and attention deficit hyperactivity disorder, which are 
common co-morbidities of obese children (for review, see (Sullivan et al., 2012);(Rofey et al., 
2009a; Rofey et al., 2009b; Waring and Lapane, 2008)). Although further studies are 
required to reliably demonstrate this causality in humans, animal models could convincingly 
show a direct association between maternal nutrition and development of abnormal social 
and aggressive behavior in rats and non-human primates (Bilbo and Tsang, 2010; Maniam 
and Morris, 2010; Raygada et al., 1998; Sullivan et al., 2010; Van Lieshout et al., 2011; 
Wright et al., 2011a). These behavioral deficits were partially attributed to perturbations of 
the serotonergic system (Sullivan et al., 2010). The serotonergic neurons originate in the 
dorsal raphe nuclei and project throughout most regions of the brain, such as the 
hypothalamus, amygdala and brainstem to name a few. Apart from its role in the regulation 
of energy balance, abnormal serotonergic signaling has been implicated in diverse functions, 
including in the development and manifestation of the aforementioned behavioral and 
mental disorders (for review, see (Marston et al., 2011)). Nevertheless, similar to the 
inconsistencies of reported hypothalamic changes in response to impaired maternal health 
and nutrition, described cellular modifications of the serotonergic system diverge and are 
even conflicting between studies (for review, see (Sullivan et al., 2012)).  
In light of these findings, future studies of metabolic programming should not only 
incorporate analyses of ARH neuronal fiber densities in these extra-hypothalamic brain areas 
implicated in the regulation of hedonic aspects of food consumption and in the modulation 
of social behavior; but also decipher putative cellular changes, in particular alterations in 
axonal formation of these “higher” neuronal circuits independent of the central 
melanocortin system to fully understand the magnitude of environmental insults during 
development on central neurocircuit formation and phenotype development. 
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4.1.3 Hormonal, cellular and molecular alterations possibly affecting ARH neuronal axon 
formation 
 
Reviewing the different studies conducted in the field of metabolic programming that have 
consistently led to an impaired ARH axon formation, the question arises which of the 
hormonal and/or nutritional alterations in response to diverse environmental insults might 
be uniformly implicated in mediating developmental defects that result in an impaired 
metabolic homeostasis. Comparison of the milk composition between control and 
postnatally HFD-fed mothers represent likely candidates responsible for this effect. In our 
model, the relatively short period of postnatal maternal HFD-exposure was sufficient to 
highly increase leptin, glucose, insulin and lipid content in the milk – factors that have all 
been implicated in brain development (for reviews, see (Bouret, 2010; Chiu and Cline, 
2010; Sakayori et al., 2013)). Similarly, maternal obesity and overweight are associated with 
alterations in insulin and leptin levels, as well as the lipid composition in the milk in humans, 
as well as genetically predisposed obese DIO or HFD-fed rats (Ahuja et al., 2011; Gorski et 
al., 2006; Houseknecht et al., 1997; Kirk et al., 2009).  
Although we did not directly assess the early postnatal serum leptin concentration in 
the offspring, the elevated milk leptin content in addition to results from other studies 
suggest that maternal HFD-feeding during the postnatal phase significantly increases 
circulating leptin in the offspring also in our model (Rother et al., 2012; Sun et al., 2012). 
The importance of well-balanced leptin levels during the postnatal phase of hypothalamic 
neurocircuit development in rodents has been convincingly demonstrated. Using obese 
leptin-deficient mice, Bouret and colleagues showed the necessity for a so-called neonatal 
“leptin surge” required for proper ARH axon formation and ultimately regulation of energy 
and glucose homeostasis (Bouret et al., 2004b). Here, the direct neurotrophic effects of 
leptin were shown to be critical in promoting neurite outgrowth to establish functional 
hypothalamic neurocircuits. Consistently, developmental hypoleptinemia, leptin resistance 
or even a prolonged leptin surge, were associated with impaired PVH innervation of ARH 
neurons (Bouret et al., 2004b; Kirk et al., 2009; Steculorum and Bouret, 2011). To date, the 
source of this critical leptin surge during development remains controversial. While it is 
likely that maternal leptin could be directly transferred from the milk to the offspring, other 
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data suggests that leptin originates mainly from the offspring’s adipose tissue itself even early 
on during development (Ahima et al., 1998; Bouret et al., 2004b; Cottrell et al., 2009; 
Rayner et al., 1997). In addition, increased milk fatty acid concentration and alterations in 
milk fatty acid composition in response to maternal HFD-feeding increase leptin levels in 
the offspring (Korotkova et al., 2002a; Korotkova et al., 2002b). In combination with the 
possible direct effects of elevated fatty acid concentration in the milk, the lipid-mediated rise 
in leptin levels could further affect hypothalamic neurocircuit development. Thus, based on 
these findings, it is highly likely that also in our model of metabolic programming, elevated 
leptin levels in the offspring interfered with the establishment of hypothalamic neurocircuits 
in response to maternal HFD-feeding during lactation. 
One striking physiological finding in our model of metabolic programming was the 
pronounced hyperinsulinemia in three-week old offspring from postnatally HFD-fed 
mothers, which was independent of the prenatal maternal diet. This drastic increase of 
serum insulin levels could originate from consumption of the hyperglycemic milk of HFD-
fed mothers, which in turn stimulates pancreatic insulin release in the neonate. Moreover, it 
has been shown that maternal milk insulin retains biological activity upon ingestion and can 
cross the intestinal mucosal-blood barrier thereby directly contributing to serum insulin 
levels in the offspring (Kinouchi et al., 1998; Mosinger et al., 1959; Shulman, 1990). 
Similar to our observations, insulin levels have been described to be upregulated in offspring 
from postnatally HFD-fed DIO rats, which also display impaired formation of ARH 
neuronal circuits (Bouret et al., 2008; Gorski et al., 2007). Since perinatal hyperinsulinemia 
has been proposed to be involved in mediating metabolic programming as early as the 1970s 
(Pedersen, 1971), our results suggest that it might do so in part by impairing hypothalamic 
neurocircuit formation. In line with this hypothesis, Plagemann and colleagues could show 
that hypothalamic hyperinsulinemia during exactly this critical postnatal period resulted in 
an impaired metabolism of the offspring throughout lifetime (Plagemann et al., 1992). 
Although the approach used by the authors to induce hypothalamic hyperinsulinemia in the 
offspring was not physiological and highly unspecific, it was the first evidence that central 
insulin signaling during the period of hypothalamic neurocircuit formation either directly or 
indirectly leads to the development of metabolic disorders throughout lifetime (Plagemann 
et al., 1992). However, if abnormal levels of insulin during the postnatal phase of 
hypothalamic neurocircuit development did play a role in predisposing for metabolic 
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disorders by interfering with ARH axon formation, why does the offspring from mothers 
consistently exposed to HFD in our model not show any gross metabolic impairments? In 
line with the occurrence of early neuronal leptin resistance, studies in humans and rodents 
have shown that offspring from obese mothers display altered insulin sensitivity, including in 
the CNS (Catalano et al., 2009; Chen et al., 2008; Gupta et al., 2009; Morris and Chen, 
2009). Although maternal insulin cannot cross the placental barrier during gestation, 
maternal glucose can permeate and stimulate fetal pancreatic insulin secretion during early 
life. Considering the hyperglycemic and insulin resistant phenotype of pregestationally 
HFD-fed mothers in our model, these maternal blood glucose excursions could have led to 
an early neuronal insulin resistance in the offspring, dampening the potentially detrimental 
effects of hyperinsulinemia on hypothalamic neurocircuit formation in postnatal life. 
However, whether neuronal insulin resistance actually occurs in response to consistent 
maternal HFD-feeding in our model still needs to be addressed. Moreover, based on 
previous publications demonstrating that maternal HFD-feeding and hyperglycemia during 
gestation lead to increased neurogenesis in the hypothalamus, we also hypothesized that 
HFD-feeding during gestation would increase neurogenesis of anorexigenic POMC neurons, 
thereby partially protecting the offspring from metabolic impairments (Chang et al., 2008; 
Steculorum and Bouret, 2011). However, analysis of the POMC neuronal cell number did 
not show any differences between offspring (data not shown). Nevertheless, as depicted 
before, in some models of metabolic programming, offspring from consistently HFD-fed 
obese mothers display strong metabolic impairments (for review, see (Plagemann, 2012)). 
These discrepancies between studies clearly highlight the necessity to thoroughly characterize 
metabolic and hormonal changes both in the mother and in the offspring in response to the 
distinct environmental insults when using any animal model to study metabolic 
programming. This thorough characterization would not only facilitate cross-comparisons 
between studies, but also allow the molecular driver(s) of the observed metabolic phenotype 
to be identified, thereby protecting the authors from drawing the wrong conclusions.  
Taken together, in addition to the well described effects of abnormal leptin levels 
during early postnatal life on the establishment of ARH neuronal projections, the distinct 
development of hyperinsulinemia prompted us to decipher whether abnormal insulin 
signaling would contribute to the impaired axon formation of POMC and AgRP/NPY 
neurons in offspring of postnatally HFD-fed mothers.   
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4.2 Abnormal neuronal insulin signaling disrupts POMC axon formation and 
predisposes for impaired glucose metabolism 
  
Insulin has been implicated in the regulation of various aspects of brain development and 
function, including synaptic plasticity, neuronal survival, proliferation and differentiation 
(for review, see (Chiu and Cline, 2010)). In addition, insulin exerts axonotrophic effects 
resulting in accelerated neurite outgrowth and increased average neurite length in cultured 
rodent fetal neuronal and human neuroblastoma cells (Recio-Pinto and Ishii, 1984; Recio-
Pinto et al., 1986; Toran-Allerand et al., 1988). However, whether these effects of insulin on 
axon formation are relevant in vivo has yet to be demonstrated. To decipher the role of 
neuron-specific insulin signaling in ARH neuronal projection formation and the relative 
contribution of hyperinsulinemia in response to postnatal maternal HFD-feeding in 
mediating metabolic programming, we genetically ablated the insulin receptor (IR) from 
POMC-neurons in offspring from control and postnatally HFD-fed mothers (POMCΔIR). 
In contrast to POMCΔIR mice, which do not have a baseline phenotype, mice lacking the IR 
specifically on AgRP-neurons display impaired regulation of hepatic glucose production 
(Konner et al., 2007). Thus, employing our feeding paradigm to POMCΔIR rather than 
AgRPΔIR offspring largely facilitated the interpretation of results and conclusions that could 
be drawn – as a proof of principle – for the role of hypothalamic insulin signaling during 
development under pathological conditions. Nevertheless, this model also displays one 
technical limitation, which warrants caution when interpreting the data. Some POMC 
progenitor cells differentiate into AgRP/NPY neurons later during development (Padilla et 
al., 2010). Consequently, IR signaling will also be genetically deleted in a minor 
subpopulation of these orexigenic neurons, possibly contributing to the observed metabolic 
and cellular effects.    
In offspring from control NCD-fed mothers, POMC-specific insulin receptor 
deficiency did not lead to any gross hypothalamic anatomical malformations, nor did it 
affect POMC or AgRP/NPY innervation to any intra-hypothalamic target site. In contrast, 
postnatal maternal HFD-feeding decreased POMC and AgRP/NPY neuronal fiber densities 
in all major intra-hypothalamic target areas, which was associated with strong metabolic 
disorders in the offspring. Under these pathological developmental conditions, POMC-
specific insulin receptor deficiency in the offspring restored POMC neuronal fiber density 
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exclusively in the posterior part of the PVH. These results suggest that as opposed to the 
effects seen in vitro, IR signaling is not essential for POMC axonal organization under 
normal developmental conditions. However, abnormal insulin action in response to 
maternal HFD-feeding exerts detrimental effects on POMC neurocircuit formation, which 
can partially be prevented by specific loss of the IR on these neurons. Our laboratory found 
similar adverse effects of aberrant hypothalamic insulin signaling in response to HFD-
exposure on energy metabolism in adult mice. Here, activation of insulin signaling in the 
VMH contributed to the diet-induced inhibition of POMC neurons and subsequent 
manifestation of metabolic disorders (Klockener et al., 2011). Of note, this effect of insulin 
signaling in the VMH was only seen under NCD-conditions (Klockener et al., 2011). 
Moreover, whereas low concentrations of insulin (i.e. 10 nM) promoted neurite outgrowth, 
chronic exposure (i.e. 500 pM for 5 days) or stimulation with high doses of insulin (i.e. 1 
µM) suppressed neurite outgrowth in a cell culture system of adult sensory neurons (Singh et 
al., 2012). Accordingly, it is conceivable that in our model, neonatal hyperinsulinemia in the 
offspring could result in an abnormal activation of insulin signaling in POMC neurons, 
thereby contributing to the disruption of melanocortin projections. Importantly, the 
sustained impairment of ARH neurocircuits throughout lifetime in the offspring from 
mothers exposed to HFD-feeding during lactation clearly highlights the apparent lack of 
plasticity of the CNS during adulthood needed to compensate for this developmental defect.    
The discrepancy between the in vitro findings and our results in POMC neurons on 
insulin’s role in axon formation under normal developmental conditions could originate 
from potential compensatory effects of type 1 insulin-like growth factor receptor (IGF1R) 
signaling. Insulin-like growth factor 1 and 2 (from now on called IGF-related peptides) 
signal via the IGF1R, which is expressed throughout the CNS, including in neurons of the 
mediobasal hypothalamus (Daftary and Gore, 2004; Lesniak et al., 1988). Although insulin 
and IGF-related peptides mainly display distinct physiological functions, similar to IR 
signaling, ligand binding to the IGF1R leads to IRS-mediated activation of PI3K and 
MAPK signaling (for review, see (Werner and Leroith, 2014)). Moreover, insulin and IGF-
related peptides not only bind to their own, but they can also bind to and activate each 
other’s receptors. Accordingly, they are also implicated in the regulation of the same 
processes, such as neurogenesis or neuron axon formation during CNS development.  Thus, 
one could speculate that potential defects caused by IR signaling deficiency on neuronal 
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development could have been masked by compensatory action of insulin and/or IGF-related 
peptide signaling via the IGF1R under normal developmental conditions. Moreover, in vitro 
studies have shown that both insulin and IGF-related peptides enhance neurite growth 
independently, but may act in concert to exert their full effects on axon formation and to 
regulate other aspects of neuronal development (Recio-Pinto and Ishii, 1984, 1988; Recio-
Pinto et al., 1986). In line with these findings, Toran-Allerand and colleagues demonstrated 
that in their hypothalamic fetal neuronal cell culture system only supraphysiological levels of 
insulin were able to induce neurite formation (Toran-Allerand et al., 1988). Hence, the 
authors hypothesized that insulin may activate the receptor of different, but closely related 
molecules, such as the IGF1R, to elicit the observed axonotrophic effect in neurons (Toran-
Allerand et al., 1988).  
To fully understand the role of insulin signaling in hypothalamic neurocircuit 
formation under normal, as well as pathological conditions in vivo, complete abrogation of 
neuronal insulin signaling by specifically deleting IR and IGF1R expression in POMC 
neurons could shed new light on these matters. However, there are some possible limitations 
to this approach, which need to be considered when interpreting the metabolic phenotype 
and (possible) hypothalamic alterations in the offspring. First, whether POMC neurons 
express the IGF1R has not yet been investigated. Second, Cre-mediated ablation of IR and 
IGF1R signaling (often referred to as “IIS” signaling) in POMC neurons could lead to 
detrimental outcomes in the offspring. Cre expression under the transcriptional control of 
the POMC promoter starts around embryonic day 12.5 and would therefore result in 
complete loss of IIS signaling during both phases of hypothalamic neurocircuit development 
possibly leading to impaired differentiation into POMC neurons or defects in neuronal 
migration (Padilla et al., 2012). Finally, some AgRP/NPY neurons express Pomc early during 
development, which is sufficient to induce Cre-mediated IR/IGF1R ablation also in these 
orexigenic neurons (Padilla et al., 2010).  
The molecular mechanisms how insulin and/or IGF-related peptides mediate neurite 
formation remains unknown. Some experiments indicate that both insulin and IGF-related 
peptides promote synthesis of proteins, such as neurofilament subunits or the presynaptic 
growth-associated protein 43, which are implicated in neuron axon formation, growth and 
stabilization in a PI3K/MAPK-dependent manner (Liu et al., 2012; Wang et al., 1992). 
However, further studies are needed to decipher downstream targets of insulin and/or IGF-
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related peptides critical for neuron axon formation that might be impaired upon abnormal 
hormonal signaling in response to maternal HFD-feeding.  
Although we initially decided against studying the contribution of AgRP/NPY 
neuron-specific insulin signaling in our model, the specificity of both the cellular and 
metabolic improvements in POMCΔIR offspring from postnatally HFD-fed mice demands 
further investigation of cell-type specific alterations in response to distinct hormonal insults 
during development to fully understand processes underlying metabolic programming. 
Interestingly, a recent study published by Bouyer and Simerly demonstrated specific 
restoration of AgRP/NPY innervation of the posterior PVH upon intraperitoneal leptin 
injections during the postnatal period in leptin-deficient mice (Bouyer and Simerly, 2013). 
However, whether abnormal levels of insulin have identical effects on the axonal projections 
of AgRP neurons as we described for POMC neurons or whether insulin action impacts on 
an AgRP neuronal subpopulation that innervates other intra-or extrahypothalamic target 
sites possibly responsible for different metabolic impairments in offspring from postnatally 
HFD-fed mothers remains to be identified.  
Taken together, despite the multitude of studies demonstrating an axonotrophic 
effect of insulin on neurons in vitro, based on our data, IR signaling per se does not seem to 
be essential for neuronal axon formation of POMC neurons under normal developmental 
conditions in vivo.  Nevertheless, hyperinsulinemia in response to maternal postnatal HFD-
feeding specifically contributes to impaired POMC innervation to a distinct compartment of 
the PVH implicated in the regulation of the autonomic nervous system. Our findings 
provide further evidence for the existence of distinct subpopulations of POMC neurons that 
seem to diverge in their projection sites and thus in their relative contribution to regulate 
different aspects of energy and glucose homeostasis. These results highlight the necessity to 
further dissect the effect of specific hormonal alterations on individual neuronal populations 
in response to developmental insults.  
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4.3 A novel brain-pancreas circuit regulating glucose homeostasis? 
 
The site-specificity in the rescue of POMC axonal formation to the preautonomic, but not 
to the neuroendocrine compartment of the PVH or any other intra-hypothalamic target site 
in POMC-specific IR-deficient offspring from postnatally HFD-fed mothers might result 
from the cellular heterogeneity of this neuronal population. Only a subset of POMC 
neurons is insulin-responsive and this subpopulation of neurons is distinct from leptin-
responsive POMC neurons in the ARH (Williams et al., 2010). Thus, loss of IR-signaling 
under hyperinsulinemic conditions might only lead to a beneficial effect on a subpopulation 
of POMC neurons, which might predominantly target the posterior part of the PVH. 
However, future studies will clearly have to address the mechanistic basis for the selective 
effect of IR-signaling on projection formation to the PVH.  
Strikingly, the specific restoration of the α-MSH fiber density to the posterior PVH 
was associated with an improvement of glucose homeostasis without affecting adiposity or 
insulin resistance in POMCΔIR offspring from postnatally HFD-fed mothers. The posterior 
PVH harbors some neuroendocrine neurons expressing vasopressin, oxytocin or TRH 
implicated in the regulation of pituitary hormones, but mainly contains preautonomic 
neurons that project to various regions in the brainstem, including to parasympathetic and 
sympathetic preganglionic neurons located in the dorsal motor nucleus of the vagus (DMX) 
and the intermediolateral column (IML), respectively (Geerling et al., 2010; Lakke and 
Hinderink, 1989). Parasympathetic and sympathetic nerve terminals innervate peripheral 
organs, such as the pancreas, liver and white adipose tissue to modulate cellular processes 
adapting behavior and metabolism to the current energetic and environmental demand (for 
review see (Marino et al., 2011)). In the pancreas, parasympathetic vagal nerve activity 
stimulates, whereas sympathetic activation inhibits insulin secretion from pancreatic β-cells 
(for review, see (Ahren, 2000)). This autonomic control of pancreatic insulin secretion is 
essential for the so-called “cephalic”, as well as “first” phase of glucose-stimulated insulin 
secretion. The cephalic phase of insulin secretion, which is triggered by sensory mechanisms 
and not by absorbed nutrients, primarily depends on direct neuronal connections between 
the taste buds and the brain stem (Berthoud et al., 1981; Berthoud and Jeanrenaud, 1982; 
Berthoud et al., 1980). In contrast, neuronal circuits responsible for the regulation of first 
phase insulin secretion are not completely elucidated, yet. However, there are studies clearly 
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demonstrating a role for ARH-residing neurons in mediating this response. First, ARH 
neurons form direct, as well as multisynaptic contacts via the PVH with neurons of the 
DMX that innervate the pancreas (Buijs et al., 2001; Jansen et al., 1997; King and Hentges, 
2011). Second, ICV application of NPY induces insulin secretion – an effect that can be 
suppressed by vagatomy (Sainsbury et al., 1997; Zarjevski et al., 1993). Third, intracarotid 
glucose injections, which exclusively increase glucose levels in the brain, but not in the 
periphery, stimulate pancreatic insulin secretion within one minute. This central response to 
glucose is mediated at least in part by neurons of the ARH and PVH, as assessed by analysis 
of neuronal activation via c-Fos staining subsequent to intracarotid glucose injections 
(Guillod-Maximin et al., 2004).  
Accordingly, the improved glucose-stimulated insulin secretion in POMCΔIR mice 
compared to their wildtype littermates from mothers exposed to HFD postnatally in our 
model suggests that the restored insulin-responsive neuronal circuit from ARH POMC 
neurons to the preautonomic compartment of the PVH plays a critical role in adapting 
autonomic nervous system activity in response to glucose excursions. To clearly decipher 
whether this neuronal circuit plays a general role in adapting glucose-stimulated insulin 
secretion, or whether this effect is exclusively due to the effects of abnormal insulin signaling 
on POMC neuronal axon formation, glucose-stimulated insulin secretion should be 
investigated in control and POMCΔIR offspring exposed to normal developmental conditions. 
In line with our hypothesis that the POMC ARH circuit to the preautonomic PVH is 
critical for adapting autonomic nervous system activity to regulate insulin secretion was the 
finding that the decreased parasympathetic innervation of pancreatic β-cells in response to 
postnatal HFD-feeding was restored to normal levels upon POMC-specific IR-deletion. 
However, it is possible that the observed decrease in parasympathetic innervation of the 
pancreas is not directly linked to the central changes in offspring from postnatally HFD-fed 
mothers. Given that these animals display various metabolic impairments and hormonal 
alterations during postnatal development, any of these changes could have led to direct 
modifications in pancreatic morphology and/or altered sensitivity to external stimuli, as 
previously described in other models of metabolic programming (for review, see (Reusens 
and Remacle, 2006)). A recent study published by Tarussio et al. demonstrated a critical role 
for glucose sensing in the brain in the control of parasympathetic activity that defines a 
CNS/pancreas axis critical for β-cell mass establishment in the postnatal period and for long-
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term β-cell maintenance (Tarussio et al., 2014). Although we did not see changes in total β-
cell mass or insulin content in response to maternal HFD-feeding or POMC-specific IR-
deficiency, we cannot exclude that alterations in glucose and/or leptin levels during postnatal 
development impacted on β-cell sensitivity or innervation resulting in the observed 
phenotype. In addition, analyses of pancreatic parasympathetic innervation were performed 
in adult animals and not before the onset of drastic metabolic impairments. Thus, improved 
glucose-stimulated insulin secretion and parasympathetic innervation of the pancreas in 
POMCΔIR offspring from postnatally HFD-fed mothers could have developed secondary to 
their partially improved metabolic milieu. To clearly decipher whether the observed 
pancreatic changes are due to neuronal hyperinsulinemia during postnatal development, 
analysis of pancreatic autonomic innervation should be conducted in much younger animals. 
Moreover, alterations in the activity of the vagal nerve and sympathetic nerve fibers should 
be investigated, as well as the relative contribution of changes in the autonomic nervous 
system to the impaired glucose tolerance. These experiments would aid in the definition of 
the molecular and cellular contributors of metabolic disorders. In addition, as depicted 
before, POMC neurons form functional neurocircuits with the DMX, directly. These ARH-
>brain stem projections are of particular importance for glucose homeostasis, as re-
expression of the MC4R specifically in the DMX and IML in an MC4R-deficient 
background restores central regulation of insulin secretion (Sohn et al., 2013). Thus, 
postnatal maternal HFD-feeding and POMC-specific IR-deficiency could directly impact on 
the formation of these neurocircuits and thereby program the offspring for altered 
autonomic nervous system activity. However, given the scarcity of ARH-neurons that 
project to the brainstem (approximately 50-100 POMC neurons) (Zheng et al., 2005), 
sophisticated retrograde tracing experiments in combination with additional transgenic 
neuronal markers would be necessary to reliably detect putative cellular changes in these 
brain areas. Although these experiments were beyond the scope of this study so far, the 
undisputable importance of this direct melanocortin-dependent ARH->brain stem circuit 
regulating autonomic nervous system activity demands further investigation to decipher 
whether they may contribute to the observed phenotypes.   
Of note, apart from the ARH, the nucleus of the solitary tract (NTS) in the 
brainstem harbors approximately 200 POMC-expressing neurons, which form reciprocal 
connections to other brain areas, including the PVH and regions implicated in the 
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regulation of the autonomic nervous system (Joseph and Michael, 1988; King and Hentges, 
2011). Hence, it is possible that postnatal maternal HFD-feeding and/or POMC-specific 
IR-deficiency affected NTS POMC neuronal projections and thereby contributed to the 
metabolic and cellular phenotype in response to developmental insults. However, to date it 
is not known whether these neurons are actually insulin-responsive, during which 
developmental stage they form axonal projections and whether these innervate the DMX 
and/or IML. In addition to the relatively small number of NTS POMC neurons, this 
missing information rather excludes a major contribution of these neurons to the observed 
phenotypes in POMCΔIR offspring from postnatally HFD-fed mothers. Moreover, the fact 
that efferent PVH projections to the brainstem are already mature at embryonic day 20 and 
do therefore not represent a target for environmental insults during the postnatal phase, 
further support the hypothesis that POMC ARH axon formation to the posterior PVH itself 
is critical for the control of glucose homeostasis at least in part by modulation of the 
autonomic nervous system.    
Obesity has previously been associated with disturbed functions of the autonomic 
nervous system even in obese children (Baum et al., 2013; Greenfield and Campbell, 2008). 
In addition to our study, findings from other models of metabolic programming suggest that 
these defects may be programmed during early development. Offspring from 
undernourished mothers, which share several metabolic impairments with offspring from 
obese mothers, display decreased pancreatic parasympathetic activity in rodents (de Oliveira 
et al., 2011; Gravena et al., 2007). Moreover, perinatal HFD-exposure reduces hepatic 
sympathetic innervation in non-human primates (Grant et al., 2012). Although these studies 
did not analyze putative changes in the melanocortin circuitry, both of these models of 
metabolic programing have been associated with alterations in hypothalamic neurocircuit 
development (Grayson et al., 2010; Orozco-Solis et al., 2010). In light of these findings it is 
conceivable that alterations of the plasticity and development of peripheral organs, as 
described for the pancreas, liver, skeletal muscle and white adipose tissue in response to 
environmental insults during development, might be intimately linked to changes in the 
developing brain (for review, see (McMillen and Robinson, 2005)). Thus, our results 
underline the importance to broaden our perspectives when analyzing morphological and 
cellular changes in offspring from obese, diabetic or malnourished mothers to both 
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peripheral organs and central neurocircuits to eventually draw a more complete picture of 
developmental defects underlying metabolic programming.   
 
4.4 Nice study in rodents, but how is this all relevant to the human situation?  
 
At present – due to technical and ethical limitations – there is no data in humans referring to 
the effects of altered maternal homeostasis during pregnancy on the development of 
hypothalamic neurocircuits in the fetus. Despite the lack of knowledge concerning 
malformations of hypothalamic neurocircuits in humans, epidemiological studies have 
demonstrated the existence of critical time windows of particular vulnerability for metabolic 
phenotype development in the offspring similar to what we report in rodents. Nutritional 
deprivation during different phases of pregnancy results in distinct metabolic impairments in 
children during adulthood. In retrospective studies conducted by Ravelli and colleagues, 
maternal malnutrition during the first trimester was shown to increase the offspring’s 
incidences of obesity, whereas food scarcity during the third trimester were associated with 
impaired glucose tolerance and insulin resistance (Ravelli et al., 1998; Ravelli et al., 1976). 
Moreover, analyzing the effects of gestational diabetes mellitus (GDM) on the metabolic 
outcome of the offspring, independent of maternal BMI, provides the possibility to decipher 
the relative contribution of environmental insults on developmental processes occurring 
during the third trimester of pregnancy in humans, because GDM frequently manifests 
during exactly this period (Mumtaz, 2000). Although treatment of GDM protects the 
offspring from adverse pregnancy outcomes, poorly controlled GDM and maternal 
hyperglycemia below the official threshold for GDM diagnosis, are associated with increased 
incidences of neonatal macrosomia (Crowther et al., 2005; Metzger et al., 2008). 
Importantly, macrosomia is an early indicator for an increased risk to develop metabolic 
disorders later in life. These children further display neonatal hyperinsulinemia, pointing to 
a critical role of abnormal insulin in mediating these adverse pregnancy outcomes (Metzger 
et al., 2008). Newborns from obese mothers are insulin resistant as estimated by umbilical 
cord glucose and insulin concentrations (Catalano et al., 2009). This finding further 
supports the idea that abnormal insulin signaling during fetal development might also 
impact on organ plasticity and sensitivity in humans as it does in rodents. 
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In addition to this human epidemiological data, studies in non-human primates 
(NHP) provide substantial evidence that the developmental defects in the CNS seen in our 
model of metabolic programming might also be relevant for the accelerated propensity to 
develop metabolic disorders in response to impaired maternal health and nutrition in 
offspring from higher mammals. Apart from differences in the total duration of pregnancy 
between humans and NHPs, both phases of hypothalamic neurocircuit development occur 
in utero and follow the same pattern in terms of sequential events (Grove et al., 2005; 
Koutcherov et al., 2002). Similar to our findings in rodents, maternal HFD-feeding in 
NHPs is sufficient to predispose the offspring for metabolic disorders and is independent of 
maternal obesity (McCurdy et al., 2009). Moreover, maternal HFD-feeding during gestation 
in the NHP induces alterations in the central melanocortin circuitry and importantly, ARH 
neuronal axon formation (Grayson et al., 2010). However, due to the very low density of α-
MSH fibers throughout the hypothalamus in both groups of offspring, the authors could 
not reliably quantify POMC neuronal innervation of the PVH. This technical limitation 
was a result of the early stage of pregnancy when the authors performed their analysis. 
Nevertheless, similar to our observations in rodents, AgRP fiber density was significantly 
decreased in the PVH and equally reduced throughout the hypothalamus in NHP offspring 
from HFD-fed mothers (Grayson et al., 2006). Based on these findings, it is conceivable that 
impaired ARH neuronal axon formation might be a common phenomenon underlying 
metabolic programming across species. 
Due to the developmental differences between humans and rodents, a direct transfer 
of our results to the human situation warrants caution. Nevertheless, the existing human 
epidemiological data, as well as studies carried out in the NHP suggest that our findings 
concerning 1) the relative time-frame of particular developmental sensitivity, 2) the critical 
role of insulin in mediating these effects and 3) hypothalamic neurocircuit formation as a 
primary target for metabolic programming could also be used as a stepping stone in the 
battle to understand and prevent metabolic programming of obesity and T2DM in humans. 
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4.5 Conclusions 
 
“Heavy mothers have heavy babies” – is one oversimplified conclusion from studies 
demonstrating that maternal obesity, diabetes and hyperglycemia during pregnancy and 
lactation have long-term effects on the offspring’s future health prognoses (Plagemann, 
2012; Sullivan and Grove, 2010). However, the cellular and molecular processes critically 
involved in this phenomenon often referred to as “metabolic programming” remain largely 
unknown. Our study not only shows that the lactation period in rodents is most sensitive to 
the altered developmental environment in response to maternal HFD-feeding, but 
importantly demonstrates that the short exposure to HFD during this distinct 
developmental phase is sufficient to predispose the offspring for metabolic disorders. This 
occurs, at least in part, by impairing ARH neuronal innervation of intrahypothalamic target 
areas. The critical impact of abnormal insulin signaling particularly on ARH neuronal axon 
formation and glucose homeostasis in the offspring of postnatally HFD-fed mothers further 
provides first in-depth mechanistic evidence underlining the critical role of hyperinsulinemia 
in the predisposition for metabolic disorders as suggested by Jorgen Pedersen already in 1971 
(Pedersen, 1971). Moreover, the present study substantiates previous reports demonstrating 
the existence of highly specialized POMC neuronal subpopulations (Williams et al., 2010). 
According to our results, POMC neurons might not only diverge in their hormonal 
sensitivity, but may also differ in their specific target area innervation pattern and thus, also 
in their relative contribution to regulate different aspects of energy and glucose homeostasis. 
Since the increased adiposity and insulin resistance in offspring from postnatally HFD-fed 
mothers was not affected by POMC-specific IR-deficiency, one could speculate that these 
effects are likely attributable to developmental defects in response to abnormal insulin 
signaling in other neuronal populations or pathophysiological levels of other nutritional 
and/or hormonal signals, such as free fatty acids, leptin or ghrelin.  
The multitude of studies including our own that clearly demonstrate that 
hypothalamic neurocircuit formation is impaired in response to diverse environmental 
insults, question the general validity of the “thrifty phenotype hypothesis” postulated by 
Barker and Hales. This concept suggests that key organs regulating energy homeostasis are 
developmentally programmed in response to the perinatal environment to provide the 
organism with the most efficient phenotype to survive under the same conditions 
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throughout lifetime that they had faced during development. However, in light of the 
aforementioned findings, it seems that these cellular and metabolic changes are 
developmental defects that prohibit an efficient regulation of energy and glucose homeostasis 
rather than developmental adaptations, as they would not be beneficial under any 
circumstances. 
To eventually break through the vicious circle of impaired maternal metabolic 
homeostasis during pregnancy that in turn predisposes their children for metabolic and 
possibly mental health disorders, and who will eventually become parents themselves, more 
sensitive glucose tolerance screenings should be developed and performed in all pregnant 
women irrespective of their body mass index. Along with nutritional guidelines and well-
controlled anti-diabetic therapies, these measures could prove valuable to combat the obesity 
and diabetes epidemics at their roots.  
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5 Summary 
In light of the ever-increasing incidences of obesity and type 2 diabetes mellitus, 
development of novel therapeutic or preventative measures to combat these epidemics is of 
utmost importance. Identification of a causal relationship between an altered maternal 
metabolic homeostasis and an increased propensity for the unborn child to develop 
metabolic disorders throughout lifetime has shifted considerable amount of attention 
towards understanding the underlying cellular and molecular alterations. However, despite 
the multitude of studies already carried out in this field of research, to date we still know 
very little about the developmental alterations responsible for the increased propensity 
towards an impaired regulation of energy homeostasis.  
By employing a thorough and physiological maternal high-fat diet-(HFD) feeding 
paradigm in mice, we could demonstrate that nutritional and hormonal alterations 
specifically during lactation predispose the offspring for obesity and impaired glucose 
homeostasis. These metabolic defects are associated with malformations of the hypothalamic 
melanocortin circuitry in the offspring. Whereas the number and neuropeptide expression of 
anorexigenic proopiomelanocortin (POMC) and orexigenic agouti-related peptide (AgRP) 
neurons, electrophysiological properties of POMC neurons and posttranslational processing 
of POMC to the active neurotransmitter α-MSH remain unaffected in response to maternal 
HFD-feeding during lactation, the formation of POMC and AgRP projections to 
hypothalamic target sites is severely impaired. Moreover, abrogating insulin action in 
POMC neurons of the offspring prevents altered POMC projections specifically to the 
preautonomic paraventricular nucleus of the hypothalamus (PVH), restores pancreatic 
parasympathetic innervation and improves glucose-stimulated insulin-secretion in response 
to maternal overnutrition.   
Taken together, these experiments reveal a critical developmental period of particular 
vulnerability towards altered maternal metabolic homeostasis. An abnormal developmental 
environment during exactly this period impairs hypothalamic neuronal projections at least in 
part by abnormal neuronal insulin signaling and thereby contributes to the increased 
propensity to develop obesity and impaired glucose homeostasis. 
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6 Zusammenfassung 
Angesichts der stetig wachsenden Zahl von Adipositas und Typ-2-Diabetes mellitus 
Erkrankungen steigt ebenfalls die Nachfrage bezüglich neuartiger, präventiver 
Behandlungsmethoden. Mit der Entdeckung eines kausalen Zusammenhangs zwischen 
diesen Stoffwechselkrankheiten, ungesunder Ernährung der Mutter während der 
Schwangerschaft und eines erhöhten Erkrankungsrisikos des ungeborenen Kindes wuchs 
auch das wissenschaftliche Interesse an einer Aufklärung der zugrundeliegenden Faktoren, 
die eine solche Prädisposition konstituieren. Trotz der Vielzahl an Studien, die sich dieser 
Aufklärung widmeten, sind die zellulären und molekularen Mechanismen, die für die 
beeinträchtigte Regulation der Energie- und Glukosehomöostase der Kinder adipöser und 
diabetischer Mütter verantwortlich sind, noch nicht vollständig identifiziert und verstanden 
worden. In der vorliegenden Arbeit konnten wir durch die Anwendung eines stringenten 
und physiologischen maternalen Fütterungsparadigmas in Mäusen zeigen, dass ein erhöhter 
Fettgehalt im Futter während der Stillphase ausreichend ist, um die Energiehomöostase des 
Nachwuchses nachhaltig zu stören. Des Weiteren konnten wir demonstrieren, dass den 
beobachteten metabolischen Veränderungen eine starke Fehlbildung des zentralen 
Melanocortin-Systems im Hypothalamus, das eine wichtige Rolle in der Regulation der 
Energie- und Glukosehomöostase spielt, zugrundeliegt. Obwohl sich ein erhöhter Fettgehalt 
im Futter während der postnatalen Entwicklungsphase weder auf die Anzahl noch auf die 
Neuropeptid-Expressionsprofile der hypothalamischen anorexigenen POMC und 
orexigenen AgRP/NPY Neurone auswirkt, findet die Innervierung dieser beiden 
Neuronenpopulationen von hypothalamischen Zielregionen nicht vollständig statt. Dieser 
Entwicklungsdefekt ist teilweise auf eine veränderte neuronale Insulin-vermittelte 
Zellantwort zurückzuführen, da eine spezifische Deletion des Insulin Rezeptors von POMC 
Neuronen die Dichte von POMC Nervenfasern im prä-autonomischen nucleus 
paraventricularis des Hypothalamus, sowie die parasympathische Innervierung des Pankreas 
wiederherstellt und die Glukose-stimulierte Insulin Sekretion verbessert. Zusammenfassend 
lässt sich aus unserer Studie schließen, dass eine Veränderung des hormonellen Milieus in 
Folge einer fettreichen Ernährung während einer kritischen Phase der hypothalamischen 
Entwicklung mit der Etablierung des zentralen Melanocortin-Systems interferiert. Ein 
Defekt dieser Entwicklungsprozesse, die sich im Menschen während des dritten Trimesters 
der Schwangerschaft ereignen, trägt zu einer lebenslangen Prädisposition für metabolische 
Krankheiten des Nachwuchses bei.  
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